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ABSTRACT 
Mycobacterium ulcerans is the causative agent of Buruli ulcer (BU), a necrotizing skin disease 
endemic to West Africa and Australia. The cytopathicity, cell cycle arrest and 
immunosuppression characteristic of BU are attributed to the production of a plasmid-encoded, 
macrolide toxin, mycolactone. The core of mycolactone is a product of two large polyketide 
synthases (PKS) and is conserved among all mycolactone congeners.  Heterogeneity of the 
toxin is a result of differences in the polyketide side chain, the product of a third PKS. The 
mycolactone plasmid (MP) was initially thought to be restricted to M. ulcerans.  However, 
other mycolactone producing mycobacteria (MPMs) have now been identified in association 
with diseased frogs and fish.  Although plasmids are common in environmental mycobacteria, 
nothing is known about the ability of these plasmids to participate in horizontal transfer.   This 
work investigates the expression of mycolactone in heterologous hosts, M. fortuitum and M. 
marinum, as well as the ability of MPMs to participate in conjugation.  
 In this work a 152 kb fragment of the 154 kb MP plasmid from M. ulcerans 1615 was cloned 
into pBeloBAC11 and introduced into E. coli.  This plasmid, pMYCO7017, contains the 
mycobacterial plasmid origin of replication as well as the mycolactone gene cluster.  A 
Kanamycin resistance gene was introduced into pMYCO7017 by transposon mutagenesis.  A 
construct, pMYCO7017::TnKm, containing an insertion outside the mycolactone gene cluster, 
was isolated for further work.  Electroduction was used to transfer pMYCO7017:TnKm from 
its E. coli host into both M. marinum 1218 and a plasmid minus strain of M. fortuitum. 
One M. marinum and four M. fortuitum transformants were verified by PCR analysis.  Lipids 
were extracted from the transformants, and then analyzed by TLC and cytotoxicity assay, but 
results were inconclusive.  However, when lipid extracts were analyzed by mass spectrometry 
and HPLC, a novel molecule was discovered indicating that one transformant, M. fortuitum 
10394.6 (pMYCO7017::TnKm) was able to produce the mycolactone core.  This work is the 
first example of heterologous expression of an M. ulcerans mycolactone PKS genes.  
Importantly, the gene cluster contained on pMYCO7017::TnKm is expressed.  These results 
further suggest that the requirements for synthesis of the mycolactone core differ from those for 
the side-chain.  
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CHAPTER 1 : LITERATURE REVIEW 
1.1  Buruli ulcer disease 
1.1.1   Ecology and environment 
 Buruli ulcer is an emerging disease associated with lethargic rivers, stagnant swamps and 
other inert water bodies in tropical (Van der werf, 1999) and temperate climates 
(Johnson, 1999) in over thirty countries around the world (WHO).  In highly endemic 
areas of West Africa, the prevalence of Buruli ulcer may be as high as 151 cases per 
100,000 people and may be equal to or greater than rates of tuberculosis infection 
(Amofah, 2002). Although the exact mode of transmission remains elusive, it is thought 
that Mycobacterium ulcerans, the causative agent of Buruli ulcer, is introduced into the 
human host through trauma to the skin. This hypothesis has been supported by case-
control studies in Benin (Debacker, 2006), Cameroon (Pouillot, 2007), southeastern 
Australia (Quek, 2007), and Ghana (Raghunathan, 2005).  These studies revealed that the 
risk of Buruli ulcer disease is decreased when people wear protective clothing, namely 
long trousers and long sleeve shirts, which help to shield the skin.  
The specific ecological niche of M. ulcerans has not yet been determined and after 
dozens of years, there is only one example of an M. ulcerans culture obtained from the 
environment (Portaels, 2008). Additionally, the exact mode of transmission of Buruli 
ulcer disease is still unknown, but several different routes of infection are currently being 
investigated.  M. ulcerans has been shown to form biofilms on aquatic plants (Marsollier, 
2004) and the bacteria may be introduced into the skin by a prick from sharp grasses or 
weeds (Meyers, 1974). While direct contact with endemic water bodies in certain African 
countries is a documented risk factor for Buruli ulcer disease (Raghunathan, 2005), only 
a small percentage of cases in Australia are associated with direct contact with 
contaminated water.  However, many Australian Buruli ulcer patients reported spending 
time within close proximity to swampy or marshy water bodies. This observation 
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suggests that direct contact with contaminated waters is not always necessary for a person 
to acquire Buruli ulcer disease.   
Scientists are now searching for potential vectors, namely insects that may harbor the 
bacterium and transmit it from contaminated water sources to the human host.  Marsollier 
and colleagues have shown that a predacious water insect, Naucoridae, can be 
experimentally infected with M. ulcerans and that the bacterium is able to colonize the 
salivary glands of these predacious aquatic insects. The insects can then transmit M. 
ulcerans to mice through a bite (Marsollier, 2002), raising the possibility that these 
predacious, biting insects may be potential vectors in Buruli ulcer transmission. In the 
Daloa region of the Ivory Coast, an area heavily endemic for Buruli ulcer, up to 5% of 
Naucoridae collected from the environment test positive for M. ulcerans DNA 
(Marsollier, 2002).  
Mosquitoes are known to be a vector for several diseases of human importance including 
Malaria, Dengue Fever, and Yellow Fever, to name a few.  Consequently, mosquitoes are 
also being investigated as potential vectors for transmission of Buruli ulcer disease.  
Mosquitoes were collected and pooled into groups of 1 – 23 individuals from six different 
locations during a Buruli ulcer outbreak in Australia (Fyfe, 2007).  Two out of 42 
mosquito pools tested PCR positive for IS2404, IS2606, and KR, M. ulcerans - specific 
DNA sequences (Fyfe, 2007).  Further research is needed to elucidate the extent of the 
role of mosquitoes in transmission of Buruli ulcer. 
During the on-going search for the environmental niche of M. ulcerans, PCR has been 
used to examine a variety of environmental samples, resulting in M. ulcerans DNA being 
detected in water filtrate, biofilms, vertebrates and invertebrates (Williamson, 2008). This 
illustrates that M. ulcerans is widely distributed in aquatic environments and suggests 
that there may be some kind of trophic role in transmission of the bacterium to humans.  
It is possible that there is not simply one mode of transmission and, in fact, there may be 
multiple pathways of infection occurring simultaneously in endemic sites around the 
world. 
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1.1.2    Pathology and clinical presentation of Buruli Ulcer Disease 
Buruli ulcer disease often begins as an innocuous nodule or papule, similar in appearance 
to a spider bite, and surgical excision at this stage is usually curative (Van der werf, 
1999).  However, the harmless initial appearance of the disease, often in combination 
with various socio-economic factors and cultural beliefs, may partially explain why 
individuals in this stage of infection may not seek medical treatment.  Next, the infection 
may progress to large areas of indurated skin, called plaques, or sizeable areas of edema.  
If left untreated, these preulcerative lesions can develop into large, necrotic ulcers within 
weeks to months (Raghunathan, 2005). The exact incubation time for the disease is 
unclear due to the slow growth of the causative organism and the uncertainty of exactly 
how the disease is transmitted.  Figure 1 shows both the non-ulcerative and ulcerative 
stages of Buruli ulcer disease. 
Buruli ulcer disease can be clinically diagnosed by (1) culture of M. ulcerans from 
ulcerative lesions, (2) detection of acid fast bacilli (AFB) in lesions, (3) histopathological 
features, and/or (4) PCR detection of M. ulcerans DNA in patient sample (Guarner, 
2003).  Differential diagnoses that must be ruled out include squamous cell carcinoma, 
tropical phagedemic ulcer, actinomycosis, noma, leishmaniasis, yaws, and scrofuloderma 
(Guarner, 2003). 
Buruli ulcers can cover up to 15% of the skin surface (George, 1999) and will have 
undermined edges.  There is generally necrosis of the subcutaneous fat, which leads to 
subsequent sloughing of the overlying skin (Van der werf, 1999).  Another defining 
characteristic of Buruli ulcers is the relative lack of immune cells present at the site of 
infection and the absence of an inflammatory response.  Antibiotic therapy has shown 
little success in treatment of Buruli ulcer.  Surgical excision of diseased tissue, with 
margins extending into healthy tissue, followed by skin grafting is currently the best 
treatment available for patients. 
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Figure 1. The non-ulcerative and ulcerative stages of Buruli ulcer disease. 
Surgical excision and skin grafting are often the only treatment option for patients with 
the ulcerative stage disease.  This surgical treatment is usually curative, but often leaves 
patients with complications, such as joint contractures. (Photographs from the World 
Health Organization website, http://www.who.int/buruli/photos/en/index.html)  
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Acid-fast bacilli can be readily detected in the sloughed skin (Van der werf, 1999) and 
extracellular M. ulcerans can be isolated from discrete infectious foci within the center of 
ulcerative regions.  However, tissue necrosis usually extends a great distance from the 
actual site of bacterial infection, which led researchers to hypothesize that M. ulcerans 
may produce a diffusible toxic substance (Connor, 1965). 
1.2  Mycolactone, a polyketide-derived macrolide toxin 
1.2.1   Background information and mycolactone discovery 
As clinicians continued to study the pathology of Buruli ulcer disease, it became clear 
that the tissue damage characteristic of Buruli ulcers often extends beyond the scope of 
discrete M. ulcerans infectious foci.  In 1965, Connor and Lunn hypothesized that a 
bacterial exotoxin may be responsible for the expansion of these necrotic ulcers (Connor, 
1965).  There were multiple attempts to isolate, identify and characterize the M. ulcerans 
toxin with preliminary reports describing it as a heat-stable substance present in sterile 
culture filtrate (Hockmeyer, 1978), (Krieg, 1974), (Olson, 1995).  In 1974, Krieg and 
colleagues postulated that the M. ulcerans toxin was a phospholipoprotein – 
polysaccharide complex.   
The toxin was known to be present in sterile filtrate (SF) and preliminary reports 
suggested that the toxin was proteinacious. George et al exposed SF from M. ulcerans 
broth cultures to protease enzymes with the intent to inactivate the toxin (George, 1998).  
However, protease – treated SF showed the same level of cytotoxic activity on L929 
fibroblast cell cultures as untreated SF.  Additionally, proteins are inactivated by 
excessive heat, as this type of treatment causes irreversible denaturing.  The cytotoxic 
activity in M. ulcerans sterile filtrate was not heat sensitive.  These two experiments, 
taken together, illustrated that the M. ulcerans toxin was not a protein (George, 1998). 
In the same study, log phase cultures of M. ulcerans were subjected to an extraction 
process, which utilized a 2:1 ratio of chloroform and methanol, in order to further purify 
the toxic substance from the SF.  Proteins, salts, and highly polar molecules separate into 
the aqueous phase, while the organic phase retains most of the cell-derived lipids 
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(George, 1998).  The organic phase was dried down and acetone was added to precipitate 
the non-soluble phospholipids, leaving less polar lipid molecules in solution.  Thin layer 
chromatography (TLC) was used to further separate and purify the various lipid species 
present in the sample. Two separate lipid bands isolated from the TLC plates were 
cytotoxic to L929 murine fibroblasts in cell culture (George, 1998).  Early suspicions 
were confirmed; M. ulcerans does produce an exotoxin, which was ultimately 
characterized as a lipid (George, 1998).  In 1999, the M. ulcerans lipid toxin was further 
described as a lipid-like polyketide and given the name, “Mycolactone” (George, 1999). 
1.2.2   Biological activity of mycolactone 
Mycolactone is a polyketide – derived macrolide consisting of a 12 membered macrolide 
ring connected to a polyketide side chain (Stinear, 2004).  Macrolides are lipid like 
molecules that are smaller than proteins, but have extremely potent biological activities 
(George, 1999).  M. ulcerans belongs to the order Actinomycetales and members of this 
order are well known to produce macrolides as secondary metabolites, which, in turn, 
have diverse biological effects on eukaryotic cells.   Erythromycin (antibiotic), rapamycin 
(immunosuppressant), FK506 (immunosuppressant), amphotericin B (antifungal), and 
avermectin (antihelmetic) are all examples of well known macrolides (George, 1999).   
Buruli ulcers are characterized by extensive necrosis of the dermis and subcutaneous 
adipose tissue, with the edges of the ulcerative lesions undermined (Read, 1974).  There 
is a surprising lack of inflammatory response and ulcers are non-purulent and painless.  
The same observations can be made when M. ulcerans bacterial cells are injected into the 
dermis of guinea pigs (Read, 1974), (George, 1999).  More importantly, since the 
isolation and characterization of the mycolactone toxin, it has been shown that injection 
of the toxin alone is sufficient to produce the redness, edema, and painless ulceration 
characteristic of Buruli ulcer disease (M. ulcerans infection) (George, 1999).  Several 
studies, using both the guinea pig model of infection and cell culture, have investigated 
the biological effects of M. ulcerans, sterile culture filtrate, and purified mycolactone 
(Adusumilli, 2005), (Coutanceau, 2007), (Dobos, 2001), (En, 2008), (George, 1999), 
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(George, 2000), (Guarner, 2003), (Gooding, 2001), (Synder, 2002), (Torrado, 2007), 
(Read, 1974). 
In 1974, Read and colleagues first utilized cell cultures of L929 murine fibroblasts to 
more closely study the cytopathic effect (CPE) of M. ulcerans culture filtrate (CF).  The 
biological effects of mycolactone on L929 murine fibroblasts in cell culture are now well 
documented and this method of cytopathicity assay is commonly used to ascertain the 
CPE of M. ulcerans cells, CF, lipid extracts, and purified mycolactones.  After 24 hours 
of exposure to CF (which contains mycolactone as well as multiple bacterial-derived 
proteins) (Read, 1974) or pure mycolactone (George, 1999), L929 murine fibroblasts will 
round up and arrest in the G0/G1 stage of the cell cycle.  This is largely due to radical 
alterations in cytoskeletal rearrangement (Synder, 2002). Forty eight hours post-exposure, 
L929 cells (1) decrease in cell number and size, (2) have pyknotic nuclei that are 
displaced toward the cell wall, (3) display karyorrhexis (fragmentation of the nucleus), 
and (4) lift off the cell culture plates as they become necrotic and undergo apoptosis 
(Read, 1974), (George, 1999), (Synder, 2002).   
At high doses above 15 μg/ml, mycolactone will cause L929 cell necrosis, as detected by 
lactate dehydrogenase release, after 4 – 24 hours of exposure (Adusumilli, 2005).  
Exposure to much lower amounts of mycolactone (15 ng/ml to 150 ng/ml of 
mycolactone) causes L929 murine fibroblasts to undergo apoptosis (Adusumilli, 2005).  
Additionally, work with mycolactone negative mutants of M. ulcerans has shown that the 
pathology of M. ulcerans can be replicated by mycolactone alone (Adusumilli, 2005) 
Mycolactone, a small hydrophobic molecule, is thought to enter cells by passive diffusion 
since no evidence of receptor mediated active transport has been observed (Snynder, 
2002). Once inside the cells, mycolactone localizes to the cytoplasm.  A dose-dependent 
increase in intracellular calcium levels is observed, although this is most likely secondary 
to mycolactone-induced cytoskeletal remodeling and damage to calcium containing 
compartments within the cell (Synder, 2002).  
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Mycobacterial infections with M. marinum, M. tuberculosis, and M. bovis BCG, are 
typically intracellular and can be found residing within resident macrophages.  There has 
been one report suggesting an intra macrophage growth stage of M. ulcerans in the 
human host, but M. ulcerans cells remain mostly extracellular during the disease process.  
This may be partially due to the immunosuppressive properties of the mycolactone toxin, 
which has been shown to (1) decrease TNF-α production by monocytes, (2) inhibit 
dendritic cell migration to the site of infection, and (3) inhibit dendritic cell maturation, 
which in turn prevents T cell priming (Gooding, 2001), (Coutanceau, 2007). 
Mycolactone also has analgesic properties, but the exact mechanism has not been well 
studied.  The painlessness of Buruli ulcers may lead patients to underestimate the 
seriousness of M. ulcerans infection, which in turn may explain how ulcerative lesions 
are allowed to expand to over 15% of the skin surface (En, 2008).  Recently, researchers 
have used a murine model to investigate the analgesic properties of mycolactone.  
Intraneural hemorrhage, vascular changes, thinning of the myelin lining of neural cells, 
histological damage, and general hyposensitivity are observed when mycolactone is 
injected into the footpads of mice (En, 2008).  These observations indicate that the lack 
of pain present at the site of M. ulcerans infection is due, at least in part, to actual nerve 
damage caused by exposure to mycolactone (En, 2008). 
1.2.3   Differences and similarities between M. marinum and M. ulcerans 
Mycobacteria can be broadly classified into the fast – growers, including M. marinum 
(doubling time, 6 to 8 hours (Yao, 2006)) and the slow – growers like M. ulcerans 
(doubling time approximately 36 to 48 hours (Mve-Obiang, 2003)).  M. marinum is 
commonly found in pools, aquaria, and marine environments where it is a natural 
pathogen of fish.  M. marinum is zoonotic, as it can also cause limited, intracellular, 
granulomatous infections in humans as a result of handling infected fish or exposure to 
infected environments (Ferreira, 2006).  Mycobacteriosis due to M. marinum infection 
occurs after abraded skin is exposed to contaminated water, and is characterized by skin 
lesions which are usually limited to the extremities (Stinear, 2008).  Human cutaneous 
infections caused by M. marinum can be effectively treated with drugs such as rifampin, 
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ethambutol, quinolones, doxycycline, and/or clarithromycin (Stinear, 2008).  Untreated 
infections or infections in immunocompromised individuals may develop into more 
serious conditions including tenocynovitis, arthritis, bursitis, and osteomylitis, but these 
conditions are rare (Ferreira, 2006). 
M. marinum is classically photochromogenic, meaning that exposure to light induces the 
bacterium to produce pigments, such as carotenoids.  The production of these pigments is 
protective against exposure to ultra violet light through the reduction of singlet oxygen 
species (Stinear, 2008) and supports the bacterium’s widespread distribution in the 
environment.  M. marinum cannot grow at temperatures above 37°C, with optimal 
temperatures generally ranging between 30°C and 32°C (Ferreira, 2006).  Thus 
ectotherms, such as fish and frogs, are suitable hosts.  In frogs, M. marinum infection 
causes a chronic, granulomatous, non-lethal disease and as a result, it has been 
hypothesized that frogs may be the natural environmental host for M. marinum (Ferreira, 
2006). 
M. ulcerans, on the other hand, has strikingly different phenotypic and growth 
characteristics when compared to M. marinum.  M. ulcerans is extremely 
difficult to isolate and culture directly from the environment, but it is known to 
be widely distributed in aquatic environments around the world, with clusters 
of endemic foci (Stinear, 2000).  The scope of the environmental distribution of 
M. ulcerans has been ascertained from the collection and screening of a wide 
variety of environmental samples, including both flora and fauna, which have 
tested PCR positive for M. ulcerans DNA (Williamson, 2008). 
M. ulcerans is not photochromogenic, which can be explained by the interruption of the 
gene, crtI, involved in the production of light-inducible carotenoids (Stinear, 2007).  In 
contrast to other mycobacterial infections, such as mycobacteriosis caused by M. 
marinum where the bacterium is largely intracellular, M. ulcerans remains primarily 
extracellular throughout the course of Buruli ulcer disease.  M. ulcerans, like M. 
marinum, has optimal growth between 30°C and 32°C, which explains the cutaneous 
nature of M. ulcerans infections.  The extracellular location of M. ulcerans during human 
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infection may be due to the production of the mycolactone toxin, which is cytotoxic, has 
anti-phagocytic activity and has been shown to induce apoptosis of antigen presenting 
cells (Stinear, 2007).  Additionally, the intracellular mycobacteria, M. tuberculosis and M 
.marinum, possess an ESX-1 protein secretion system responsible for the export of 
proteins involved in the formation of granulomas (Stinear, 2007).  Inactivation of this 
protein secretion system in M. marinum and M. tuberculosis reduces phagocyte uptake 
and intracellular spread.  The natural loss of this system in M. ulcerans may contribute to 
its predominantly extracellular lifestyle in the human host (Stinear, 2007). 
Despite their phenotypic differences, the recent publication of the genome sequences of 
both M. ulcerans and M. marinum has shed light on the close genetic relationship 
between these two organisms.  The 16S rRNA gene from M. ulcerans is greater than 
99.8% identical to the same gene in M. marinum (George, 1999), suggesting that M. 
ulcerans is an ecotype of M. marinum (Jenkin, 2003).   This close genomic relationship 
has also been confirmed by multilocus sequence typing (MLST) (Stinear, 2000).   These 
two species are phenotypically very different and cause distinct disease etiologies, and 
this is, in part, due to the ability of M. ulcerans to produce the polyketide toxin, 
mycolactone.  Mycolactone is critical for the destructive and necrotic pathogenesis of M. 
ulcerans, whereas M. marinum does not produce mycolactone and does not produce such 
a devastating ulcerative disease.   
It was anticipated that M. ulcerans would possess a unique mycolactone biosynthetic 
gene cluster, which would be absent in M. marinum.  Suppressive subtractive 
hybridization (SSH) has been utilized previously to identify genomic differences between 
closely related mycobacteria including M. tuberculosis, M. bovis, and M. bovis BCG 
(Jenkin, 2003).  Jenkin and colleagues took advantage of the high degree of genomic 
similarity between M. ulcerans and M. marinum and used suppressive subtractive 
hybridization (SSH) in order to identify the mycolactone synthesis gene cluster in M. 
ulcerans.  A unique type I polyketide synthase locus was identified in M. ulcerans as the 
genetic basis for mycolactone production (Jenkin, 2003). 
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 1.2.3.1   Polyketide synthase systems 
Polyketides are large, structurally diverse lipid-like compounds and are often made as 
secondary metabolites by bacteria in the order Actinomycetales (Smith, 2007), (George, 
1999).  Over 10,000 polyketides have been identified so far and are synthesized by 
assorted organisms, both prokaryotic and eukaryotic (Smith, 2007).  Polyketide synthase 
systems are common in mycobacteria, where they are often involved in the production of 
cell wall mycolates (Stinear, 2008).  Within the genome of M. marinum, there are 27 
coding sequences predicted to encode polyketide synthases (Stinear, 2008) and in the 
genome of M. ulcerans there are 12 predicted polyketide synthases (Stinear, 2007). The 
biosynthetic pathways and enzymes necessary for polyketide production can be broadly 
grouped into categories based on their architectural organization (Smith, 2007).  Type III 
polyketide synthases (PKS) are freestanding enzymes that act alone in a repetitive 
manner (Smith, 2007).  Type III PKS synthesize polyketide molecules through a series of 
multiple condensation reactions in which malonyl-CoA serves as the primary starting 
molecule and extender unit (Song, 2006).   
Type II PKS are freestanding, monofunctional enzymes that act in a repetitive manner to 
synthesize polyketides using malonyl-CoA as the main building block.  The main 
difference between type II PKS systems and type III PKS systems is that type II PKS 
systems utilize an acyl-carrier protein (ACP) domain.  The ACP is responsible for the 
translocation of the growing polyketide molecule from one free standing enzyme to the 
next for iterative condensation reactions (Smith, 2007). 
The system utilized by M. ulcerans to produce mycolactone is a type I PKS (Stinear, 
2003).  Unlike type II and type III PKS whose enzymes are freestanding, the enzymes of 
type I PKS are covalently linked into large, multi-functional megasynthases (Smith, 
2007).  The main polyketide enzymes necessary for mycolactone biosynthesis are mlsA1 
and mlsA2, responsible for production of the 12 membered toxin core, and mlsB, which 
is responsible for assembly of the side chain (Stinear, 2004). Each enzyme contains a 
specific number of discrete catalytic domains.  The catalytic domains are grouped 
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together to form an assembly line arrangement of modules, with each module containing 
its own unique set of catalytic domains.   
The arrangement and order of the catalytic domains within each module directly influences the 
structure, stereochemistry, and β carbon processing of the polyketide molecule (Bali, 2006).  
Each module has a core set of catalytic domains including: an acyl transferase (AT) domain 
that recruits chain extension units from malonyl or methyl-malonyl; a β-ketosynthase (KS) 
domain which catalyzes the elongation of the polyketide chain by forming carbon – carbon 
bonds; and an acyl carrier protein (ACP) domain that serves as an attachment site for the 
extender units as well as the growing polyketide chain (Bali, 2006).  Each module within the 
enzyme may also contain optional domains that mediate the various types of reduction of the 
growing polyketide, such as: a ketoreductase (KR) domain that adds hydrogen to –C=O groups 
to give  -C-OH; a dehydratase (DH) domain responsible for removing oxygen and hydrogen, as 
a water molecule, from the polyketide; and/or an enoyl reductase (ER) domain that reduces the 
C=C double bond to give CH2-CH2 (Bali, 2006).  Figure 2 shows the arrangement of the type I 
PKS utilized by M. ulcerans to produce the core of mycolactone. 
1.2.3.2   The mycolactone plasmid 
In 2004, Stinear and colleagues determined that the unique type I polyketide synthase locus, 
including all polyketide synthases and associated polyketide modifying enzymes responsible 
for the synthesis of mycolactone, are encoded on a large plasmid, pMUM001.  This plasmid 
was first discovered as a defined band of roughly 170 Kb that was observed during pulsed field 
gel electrophoresis analysis of undigested whole cell DNA from M. ulcerans Agy 99 (Stinear, 
2004).  Southern hybridization experiments showed that this DNA band hybridized to M. 
ulcerans – specific polyketide synthase probes (Stinear, 2004).  After BAC end sequencing, 
insert sizing and restriction fragment profiling, the polyketide synthase locus was confirmed to 
be located on a circular plasmid of 174,155 bp (Stinear, 2004).   
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Figure 2. Arrangement of the catalytic domains within mlsA1 and mlsA2, the genes 
responsible for synthesis of the mycolactone core.  
(Adapted from www.med.monash.edu.au/microbiology/research/stinear.html) 
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The M. ulcerans plasmid, pMUM001, is the first example of plasmid – mediated 
virulence in mycobacteria (Stinear, 2004), however, there is a precedent for plasmid 
borne genes involved in the biosynthesis of secondary metabolites (Stinear, 2005).  For 
example, Streptomyces rochei possesses a plasmid, pSLA2-1 that encodes both type I and 
type II polyketide synthase clusters (Stinear, 2005).  However, the M. ulcerans polyketide 
synthase genes are particularly interesting for several reasons.  These genes encode some 
of the largest proteins ever reported (Stinear, 2005). The mlsA1 PKS gene is 50,973 bp 
long and encodes a 1.8 mega Dalton (MDa) protein.  The mlsA2 PKS gene is 7,233 bp 
long and encodes a 0.26 MDa protein.  These two genes together are responsible for 
synthesis of the mycolactone core.  The mlsB gene is 42,393 bp long and encodes a 1.2 
MDa protein responsible for production of the mycolactone side chain (Stinear, 2005).   
Another striking feature of the M. ulcerans mycolactone polyketide synthase (PKS) locus 
is that these three polyketide synthase genes are highly repetitive, with large segments of 
nucleotides with 99.7% sequence identity.  Only 9.5 Kb out of the total 105 Kb of coding 
sequence dedicated to these three PKS genes consists of unique, non-repetitive DNA 
sequence (Stinear, 2004).  Additionally, there is also greater than 97% sequence identity 
among the functional domains of the 18 PKS modules of the mycolactone type I 
polyketide synthase system (Stinear, 2004). 
There are 81 predicted protein coding sequences located on pMUM001, with 
roughly 105,000 bp out of 175,155 bp dedicated to the main PKS genes 
(Stinear, 2005).  The plasmid also has multiple copies of IS2404 and IS2606, 
insertion sequence elements (IS) that are generally positioned on either side of 
the PKS genes (Stinear, 2004). Other accessory genes involved in mycolactone 
production are: mup053, which encodes a p450 monooxygenase thought to 
hydroxylate the twelfth carbon of the mycolactone side chain and the mup045 
gene that encodes a Fab-H like type III ketosynthase thought to catalyze the 
ester bond formation necessary to join the mycolactone core and side chain 
(Stinear, 2004).  Additionally, pMUM001 has genes that are crucial the 
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replication, repA, and partioning, parA, of the plasmid so it may be passed on 
to future daughter cells (Stinear, 2004).  Figure 3 illustrates a circular 
representation of pMUM001 as constructed by Stinear et al. 
Currently, scientists believe that M. ulcerans has evolved from a M. marinum 
progenitor and diverged into a separate clonal lineage through acquisition of 
foreign DNA, namely the mycolactone plasmid, pMUM001 (Stinear, 2005). 
There is a precedent for this type of evolutionary bottleneck, as it has been 
observed for M. leprae, Y. pestis, and B. pertussis, to name a few (Stinear, 
2007).  M. ulcerans has all the genomic characteristics of a bacterium that has 
experienced such an event, including: (1) the proliferation of insertion 
sequence elements (there are 209 partial or complete copies of IS2404 and 83 
copies of IS2606 in the M. ulcerans genome); (2) accumulation of pseudogenes 
(M. ulcerans has 743 predicted genomic pseudogenes); (3) chromosomal 
rearrangements; (4) genome downsizing (M. ulcerans genome is 5.6 Mb 
compared to the M. marinum genome of 6.6 Mb (Stinear, 2008); and (5) the 
acquisition of foreign genes, often via plasmids or bacteriophages (Stinear, 
2007).   
Although, the consensus is that M. ulcerans acquired the mycolactone plasmid through 
some type of horizontal gene transfer, the exact origin of the mycolactone plasmid has 
not been determined.  The repA gene of pMUM001 shares 68.3% amino acid identity 
with the repA of pJAZ38, a plasmid harbored by M. fortuitum (Stinear, 2004).  The 
polyketide synthase system possessed by M. ulcerans has strong homology to two 
different PKS systems within the genome of M. marinum, but seems to be more closely 
related to PKS systems harbored by Streptomycetes (Stinear, 2008).  It is possible that M. 
ulcerans acquired a core set of PKS genes from a bacterium in the Streptomycetes genra 
(Stinear, 2005) and that the mycolactone PKS system, as it exists today, has evolved as a 
result of multiple recombination and duplication events (Stinear, 2004).  Insertion 
sequence elements, like those found on the mycolactone plasmid, are known to mediate 
such duplications and rearrangements (Stinear, 2005).  
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Figure 3. Circular map of the mycolactone plasmid, pMUM001.  
Colors represent the functional classification of each gene (red, replication; light blue, 
regulation; light green, hypothetical protein; cyan, insertion sequence elements; yellow, 
intermediate metabolism; gray, lipid metabolism) (Stinear, 2004). 
 
Even though the exact manner of plasmid acquisition and evolution of the mycolactone gene 
cluster are not fully understood, it is clear that the ability of M. ulcerans to produce mycolactone 
has provided a survival advantage for the bacterium.  Mycolactone could play a role in the 
colonization and/or survival of M. ulcerans in an as-of-yet undiscovered environmental niche, as 
it is unlikely that mycolactone’s cytotoxicity to human cells is part of the bacterium’s primary 
survival strategy (Stinear, 2005).   
M. ulcerans isolates from diverse geographic locations around the world produce a 
heterogeneous mixture of mycolactone congeners that have been designated A through D (Mve-
Obiang, 2005).  The structure of the toxin core remains constant, but M. ulcerans strains have 
been shown to produce variations in the toxin’s side chain, which may be linked to the severity of 
disease process (Mve-Obiang, 2005).  Multiple different M. ulcerans isolates have been screened 
in order to characterize their mycolactone profiles.  Mycolactone A/B is produced as the major 
mycolactone species by isolates from Malaysia and Western Africa and as a minor toxin species 
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by M. ulcerans strains from Australia, Japan, and China.  Mycolactone A/B is not produced by 
strains from Mexico (Mve-Obiang, 2005).  M. ulcerans isolates from Australia produce mainly 
mycolactone C, while strains from Japan and China produce mainly mycolactone D (Mve-
Obiang, 2005).  Figure 4 shows the structure of some of the mycolactone congeners. 
1.2.4   Other mycolactone producing mycobacteria 
The pathology of Buruli ulcer disease is now better appreciated since the discovery that M. 
ulcerans produces a cytotoxic polyketide, mycolactone, which is responsible for a majority of the 
tissue damage characteristic of Buruli ulcers (George, 1999).  Additionally, it is exciting that the 
mycolactone PKS gene cluster has been discovered and that this locus is located on an 
independently replicating plasmid, which may have been acquired by M. ulcerans through 
horizontal gene transfer (Stinear, 2004).  Plasmids are generally considered to be movable genetic 
elements, but this particular plasmid was thought to be unique and limited to the ulcerans species 
of mycobacteria.  Additionally, horizontal transfer systems are not well documented in 
mycobacteria, with only a few examples of conjugation demonstrated in M. smegmatis (Parsons, 
1998), (Bhatt, 2002), (Bhatt, 2003), (Wang, 2003), (Coros, 2008).  
 
 
Figure 4. The structure of mycolactone. 
The structure of two mycolactone congeners produced by M. ulcerans isolates.  Notice 
that the structural differences are limited to the toxin’s fatty acid sidechain. 
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1.2.4.1   M. liflandii 
In 2001, an M. ulcerans-like infection spread through a colony of African Xenopus 
tropicalis and Xenopus laevis frogs at the University of California in Berkley (Trott, 
2004).  The disease presented as cutaneous ulcers, with some incidence of generalized 
edema.  Ziehl-Neelson staining and microbiological culture of bacteria collected from 
diseased frogs clearly indicated that the frogs were suffering from a mycobacteriosis 
(Trott, 2004).  Sequence analysis was performed on the following genes: hsp65 (heat 
shock protein), 16sA, 16sB, 16sC (highly conserved regions of the 16s rRNA gene), ITS 
(an internal spacer between the 16s and 23s rRNA), rpoB (RNA polymerase B subunit), 
IS2404, and IS2606.  Genetic examination of mycobacterial isolates did not provide a 
clear-cut identification of the etiological agent, with sequence homology to both M. 
ulcerans and M. marinum, two very closely related species (Trott, 2004).    
Mve-Obiang and colleagues further characterized this non-ulcerans, mycolactone 
producing mycobacterium (MPM) as a new species, M. liflandii (Mve-Obiang, 2005).  M. 
liflandii was PCR positive for five pMUM001-specific genes including, mlsA1, mlsB, 
mup045, mup037 (a type II thioesterase), and repA (Mve-Obiang, 2005).  These genes 
had 99% sequence identity to the same genes in M. ulcerans.  Additionally, pulsed field 
gel electrophoresis of M. liflandii DNA plugs showed a unique band of 180 Kb that 
hybridized to pMUM001-specific genes (Mve-Obiang, 2005).  Lipids were extracted and 
analyzed by mass spectrometry, which detected a molecule of m/z 737.7.  Further 
analysis by tandem MS-MS revealed the mycolactone core at m/z 429.5 and a peak 
representing the mycolactone side chain at m/z 331.4, 28 daltons less than the side chain 
of mycolactone A/B.  This new mycolactone molecule was designated mycolactone E 
(Mve-Obiang, 2005).  The mycolactone plasmid possessed by this newly discovered 
MPM is roughly 180 Kb, slightly larger than the M. ulcerans mycolactone plasmid (Yip, 
2007). 
1.2.4.2  M. marinum MPM species 
Mycobacteriosis in fish caused by infection with M. marinum has been well documented 
for decades, but in the early 1990s, M. marinum infections became especially problematic 
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in Israeli aquaculture systems (Ucko, 2002).  Mycobacteria have been isolated from fish 
in Israel and compared to M. marinum on the basis of 16s rRNA and hsp65 gene 
sequence alignments.  All Israeli fish isolates have been categorized as M. marinum, but 
were clearly divided into two strains; mycobacterial strains infecting marine fish and 
those strains infecting freshwater fish (Ucko, 2002).  Furthermore, mass spectrometry 
analysis of lipids extracted from the Israel fish isolates proved that these M. marinum 
strains were unique based on their ability to produce mycolactone F, m/z 723 (Ranger, 
2006).  MS/MS analysis of these lipids detected the mycolactone core m/z 429, the 
structure of which remains constant throughout all mycolactone congeners described to 
date (Ranger, 2006).   
These newly discovered MPM strains produce a novel mycolactone molecule that differs 
from other toxin species due to differences in the fatty acid sidechain.  Figure 5 shows 
the structure of mycolactone F compared to mycolactone A/B.  Like other mycolactone 
producing mycobacteria, these M. marinum Israeli fish isolates possess a form of the 
mycolactone plasmid that ranges in size from 180Kb to 200 Kb, slightly larger than the 
plasmid harbored by M. ulcerans strains (Yip, 2007).  
1.2.4.3   M. pseudoshottsii 
Since the discovery and characterization of M. liflandii, several MPMs have been 
discovered and characterized.  1997 saw the beginning of a mycobacteriosis outbreak of 
striped bass, Morone saxatilis, collected from the Chesapeake Bay and some of its 
tributaries.  Researchers were able to obtain multiple different mycobacterial isolates 
from diseased fish, as polyinfections within individual fish were observed in 25% of 
samples (Rhodes, 2004).  Approximately 12% of fish were infected with a previously 
uncharacterized mycobacterial species (Rhodes, 2005).   
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Figure 5. The structures of mycolactone A/B and mycolactone F. 
Comparison of the structure of (A) mycolactone A/B, produced by M. ulcerans strains, 
and (B) mycolactone F, produced by M. marinum strains isolated from Israeli fish.  
Notice that structural differences are limited to the fatty acid sidechain. (Ranger, 2006) 
  
After high performance liquid chromatography analysis of mycolic acid profiles, 
biochemical testing, and observation of growth characteristics, one new isolate seemed to 
most closely resemble M. shottsii, also a new species discovered during the outbreak in 
the Chesapeake Bay (Rhodes, 2003).  However, the new mycobacterial isolate was PCR 
positive for IS2404 and IS2606, a genotypic trait of M. ulcerans.  The new isolate was 
named M. pseudoshottsii to reflect its similarity to M. shottsii, but clearly designate it as a 
new species (Rhodes, 2005). 
The 16s rRNA sequence of M. pseudoshottsii showed that this isolate was closely related 
to M. ulcerans, M. marinum MPM strain DL240490 isolated from Israeli fish, and M. 
liflandii (Ranger, 2006).  M. pseudoshottsii was PCR positive for  several mycolactone 
associated genes including repA, mlsA, mlsB, mup045, and pMUM001 insertion sequence 
elements IS2404 and IS2606 (Ranger, 2006).  M. pseudoshottsii was differentiated from 
M. ulcerans due to the absence of an M. ulcerans-specific hypothetical membrane protein 
gene, uhp-mem (Ranger, 2006).  Mass spectrometry analysis of lipids extracted from M. 
pseudoshottsii isolate L15 detected mycolactone, m/z 723, and the mycolactone core, m/z 
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429, was detected by MS/MS (Ranger, 2006).  Further analysis of the 
mycolactone molecule produced by M. pseudoshottsii led to the discovery that 
this MPM was producing yet another congener of mycolactone, designated 
mycolactone F (Ranger, 2006).  The mycolactone plasmid harbored by M. 
pseudoshottsii was determined to be 200 Kb, larger than pMUM001 found in M. 
ulcerans strains (Yip, 2007). 
DNA-DNA hybridization (DDH) studies have been utilized to compare these 
newly discovered MPMs with M. ulcerans in the hopes of shedding some light on 
the evolutionary story of mycolactone production.  This method of genetic 
comparison has been used for over 30 years in bacterial taxonomy to determine 
the degree of relatedness between different species and/or strains (Yip, 2007).  
Based on this method of comparison, MPMs are very closely related to M. 
ulcerans (Yip, 2007).  Moreover, it is significant that MPMs are 99% identical to 
each other at the nucleotide level, as shown by multilocus sequence analysis 
(MLSA) and variable number tandem repeat loci (VNTR) (Yip, 2007).  MLSA 
has been used to compare and contrast the frequency of mutation found in 
chromosomal genes versus the frequency of mutation of genes found on the 
mycolactone plasmid.  
 In MPMs, the frequency of mutation of chromosomally encoded genes was 
synonymous with the mutation frequency of plasmid-borne genes, suggesting 
that the mycolactone plasmid co-evolved with all mycolactone producing 
mycobacteria (Yip, 2007).  These data imply that MPMs have evolved from a 
common progenitor after acquisition of the mycolactone virulence plasmid and 
not as a result of multiple exchanges of the plasmid (Yip, 2007).  Present day 
differences between M. ulcerans and other MPMs have evolved as these 
mycobacteria have evolved to occupy different ecological niches (Yip, 2007). 
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1.3   Plasmids in mycobacteria 
1.3.1   Plasmids in non-ulcerans mycobacterial species 
Plasmids have been described in multiple mycobacterial species isolated from both 
environmental and clinical settings.  M. avium is predominantly a pathogen of birds and 
is commonly found in the environment, but in recent years, this mycobacterium has been 
causing infections in immunocompromised patients (Beggs, 2005).  Crawford and 
colleagues were the first to identify plasmids in M. avium (Crawford, 1979) and five 
years later they characterized a 15.3 Kb plasmid, pLR7 (Beggs, 1995).  M. avium’s 
plasmid, pLR7, is very simple and is known to harbor genes encoding a Rep protein and a 
surface-associated protein (Beggs, 1995).  Although preliminary data suggests that M. 
avium strains that possess this plasmid may experience enhanced intracellular survival in 
the human host (Beggs, 1997), more research is needed to fully understand if pLR7 
enhances virulence. 
Plasmids have also been found in M. scrofulaceum, M. chelonae, and M. abscessus 
species and subspecies (Bachrach, 2000), (Gavigan, 1997), (Labidi, 1984), (Labidi, 
1992), (Meissner, 1984).  The plasmids range in size from 7 Kb up to 115 Kb and are 
typically found in low copy numbers within bacterial cells.  The 115 Kb plasmid, pVT1, 
harbored by M. scrofulaceum, is known to contain a gene encoding mercuric reductase, 
which presumptively enhances the bacterium’s survival in contaminated aquatic 
environments (Meissner, 1984).  M. scrofulaceum also has another plasmid, pMSC262 
(Bachrach, 2000).  These plasmids have not been fully annotated and the exact function 
of most of the genes remains largely unknown.   
M. fortuitum isolates may completely lack plasmids or can possess up to six or more 
individual plasmids ranging in size from 7 Kb to 112 Kb (Labidi, 1984).  Three M. 
fortuitum plasmids, pAL5000, pJAZ38, and pMF1, have been extensively studied for 
their potential utility as tools for mycobacterial genetics studies (Bachrach, 2000), 
(Gavigan, 1997), (Labidi, 1992).  Linear plasmids have been identified in other, lesser 
known mycobacterial species, including M. xenopi, M. celatum, and M. branderi,, but 
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there is no indication that these plasmids are essential to the metabolism of these bacteria 
(Picardeau, 1997). 
1.3.2   Plasmid biology and host range 
Mycobacteria, namely M. tuberculosis and M. leprae, were some of the first bacteria to 
be recognized as the causative agents of human disease, and yet knowledge of the 
molecular biology of mycobacteria continues to lag behind  that of most other groups of 
pathogenic bacteria (Bachrach, 2000).  Many of the genetic tools used in microbial 
genetics are ill suited for genetic manipulation of mycobacteria.  Mycobacteria have a 
thick, waxy, hydrophobic cell wall that makes traditional prokaryote cell lysis methods 
and genetic transformations extremely difficult.  Additionally, medically important 
pathogens, such as M. tuberculosis and M. leprae, grow extremely slow, making work 
with these microorganisms very time-consuming.   
The Rep regions of several of the plasmids identified in mycobacteria have been 
sequenced and show high degrees of sequence homology with each other (Gavigan, 
1997), (Bachrach, 2000).  Scientists are diligently investigating the host range of these 
plasmids to assess their potential use in mycobacterial transformations and heterologous 
expression of genes (Bachrach, 2000).  For example, the plasmid pCLP, harbored by M. 
celatum, cannot be replicated by M. smegmatis, but the plasmid pMF1 isolated from M. 
fortuitum, can be carried and replicated by both M. tuberculosis and M. smegmatis 
(Bachrach, 2000).  M. fortuitum’s plasmid, pJAZ38, has a rep region similar to pLR7 (M. 
avium) and pMSC262 (M. scrofulaceum) and can be successfully replicated by M. 
smegmatis (Gavigan, 1997).  M. fortuitum’s plasmid pAL5000 is one of the most well-
studied mycobacterial plasmids and has served as the basis for several mycobacterial 
vectors (Gavigan, 1997). 
Nucleotide sequencing has enabled a broader understanding of mycobacterial plasmids.  
The ability to compare the nucleotide similarity of the rep regions of various 
mycobacterial plasmids may provide useful insight into their host range.  For example, 
the repA gene from the M. ulcerans plasmid, pMUM001, shares greater than 68% amino 
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acid identity with rep from the M. fortuitum plasmid pJAZ38 and 55.6% amino acid 
identity with the same rep gene in pVT2, a plasmid harbored by M. avium (Stinear, 
2005).  
Although plasmids are common in mycobacteria outside of the M. tuberculosis complex, 
none of these plasmids have ever been directly linked to virulence until the discovery of 
the M. ulcerans plasmid, pMUM001 (Stinear, 2005).  In fact, there are very few reports 
that have even assigned functions to the genes on these plasmids and consequently, it is 
thought that lateral gene transfer of plasmid DNA between mycobacteria is not essential 
to pathogenesis or virulence (Stinear, 2005).  pMUM001, first isolated from M. ulcerans, 
is the first example of a mycobacterial plasmid that confers the ability to produce a toxin 
that is responsible for pathogenesis of the mycobacterial disease, Buruli ulcer.  
Importantly, other mycobacterial species have been discovered that possess forms of this 
plasmid and that can also produce the virulence-enhancing toxin, mycolactone.   
1.3.3   pMYCO7017 contains the majority of the M. ulcerans plasmid 
Insight into the biology and host range of pMUM001 has been hindered by (1) the slow 
growth of the plasmid’s native host, M. ulcerans, (2) difficulty performing genetic 
manipulations with mycobacteria due to the high G + C nucleotide content, and (3) the 
extremely large size of the plasmid, 174 Kb.  Additionally, like other mycobacterial 
plasmids, pMUM001 is also present in very low copy numbers within mycobacterial 
cells.  For these reasons, very little work has been done to investigate the ability of other 
non-ulcerans mycobacterial species to replicate the mycolactone plasmid and 
heterologously produce mycolactone.   
However, Stinear et al have done some work to investigate the stability of the ori region 
of pMUM001 (Stinear, 2005).  A 6 Kb region of pMUM001, encompassing the putative 
parA, repA, and ori, was cloned into the vector pCDNA2.1 and the construct was marked 
with an apramycin gene.  Electroporation was used in an attempt to introduce this 
construct into M. marinum, M. smegmatis, and M. fortuitum; however, transformation 
was only successful with M. marinum.  The M. marinum transformants were cultured 
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with apramycin as selective pressure for the transformants to maintain the vector 
construct along with the pMUM001-derived DNA.  Late log phase cultures of M. 
marinum transformants were switched to antibiotic-free media for 12 days in order to test 
the stability of the pMUM001-derived genes, ori, repA, and parA in the absence of 
selective pressure.  In the absence of antibiotic selection, M. ulcerans’ ori, repA, and 
parA genes were not sufficient to maintain the construct in M. marinum.   
The aim of this current work was to further investigate the stability of M. ulcerans 
mycolactone genes in other, faster growing mycobacterial species.  In order to 
circumvent the difficulty of direct manipulation of pMUM001, a whole-genome M. 
ulcerans bacterial artificial chromosome (BAC) library was previously constructed at the 
Clemson University Genomics Institute (Tomkins, 2001).  The hope was to create a 
BAC, with a selectable marker and an E. coli origin of replication, as well as the 
mycolactone synthesis genes.  The BAC used for this study, pMYCO7017, contains a 
152 kb fragment of M. ulcerans plasmid DNA and includes the majority of the M. 
ulcerans virulence plasmid, pMUM001.  Figure 6 shows a linear representation of 
pMYCO7017 depicting the size and location of the genes necessary for mycolactone 
production.  Notice that the pMYCO7017 construct also contains the mycobacterial 
replication (rep) and partioning (par) genes.  The creation of this construct, 
pMYCO7017, has, for the first time, enabled investigation of the host range and stability 
of the M. ulcerans mycolactone plasmid in heterologous hosts. 
 
Figure 6. Linear arrangement of pMYCO7017, total length 152 Kb. 
*  mup027c,  similar to the  IS116 / IS110 / IS902 family of transposases  
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1.4  Conjugation 
DNA can be transferred between prokaryotic cells by transformation, transduction or 
conjugation.  During transformation, a bacterial cell may take up free DNA that is present 
in the environment.  Bacteriophages are responsible for transferring fragments of nucleic 
acid between bacteria through the process of transduction.  Conjugation, on the other 
hand, is the direct transfer of DNA from one cell to another.  Each of these processes 
have been vital to inter and intra-species spread of virulence determinants, such as 
antibiotic resistance, throughout microbial communities. 
A crucial step of successful conjugative DNA transfer is intimate cell surface contact 
between the donor and recipient cells (Grohmann, 2003).  In gram negative bacteria such 
as E. coli, this close cell-to-cell contact is often established with specialized conjugative 
structures called sex pili (Grohmann, 2003).  Sex pili are similar to the structures 
involved in the type IV secretion system (Grohmann, 2003).  The donor cell uses a sex 
pilus to penetrate the gram negative outer membrane, periplasm, and inner membrane.  
To date, no sex pili have been elucidated in mycobacteria, although mycobacteria may 
possess homologous structures capable of facilitating intimate cell contact that have yet 
to be characterized. 
Plasmid DNA is almost always the centerpiece of conjugative transfer; however, it 
cannot be transferred through the narrow sex pilus to the recipient cell in its circularized 
form.  Most detailed work on plasmid conjugation apparatus has been conducted with 
gram negative organisms such as E. coli. In gram negative bacteria, the plasmid DNA 
must be nicked and a single strand of DNA may be lead through the sex pilus to the 
recipient cell, where it is copied and re-circularized.  The genes necessary for conjugation 
are often cis-acting elements, encoded on the same DNA element involved in the transfer.  
There may also be trans-acting, chromosomally encoded elements necessary for 
conjugative plasmid DNA transfer.   
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Various gram negative conjugation systems have been described, but the IncP transfer 
system present on the broad host range plasmid, RP4, serves as an excellent example to 
help better understand this process.  Two protein complexes are essential for the 
conjugative transfer of RP4; the relaxosome and the mating-pair formation (mpf) 
complex (Grohmann, 2003).  The relaxosome is a “multiprotein-DNA complex” that 
localizes to the plasmid’s origin of transfer site, oriT (Grohmann, 2003).  The relaxosome 
cleaves a specific phosphodiester bond of the double stranded plasmid DNA at a unique 
nic site within the oriT (Grohmann, 2003).  The relaxosome remains covalently bound to 
a single strand of the plasmid DNA and is then linked to the mpf complex by a TraG 
coupling protein.  It is the mpf complex that is responsible for trafficking the relaxosome-
TraG-donor DNA complex from the donor, through the sex pilus, to the recipient cell. 
Enterococcus faecalis, a gram positive bacterium, possesses a pheromone-inducible 
conjugation system.  Horizontal transfer of the pCF10 plasmid involves chromosomally 
encoded pheromones which act on plasmid-encoded response machinery.  Horizontal 
transfer of the pCF10 plasmid occurs when donor cells encounter high concentrations of 
cCF10 pheromone produced by recipient Enterococcus cells.  Self-induction of 
conjugation by endogenous production of cCF10 pheromone by donor Enterococcus cells 
is reduced by the plasmid encoded membrane protein, PrgY. Additionally, donor cells 
also produce endogenous iCF10, an inhibitor peptide that neutralizes residual endogenous 
pheromone that escapes the control of PrgY (Kozlowicz, 2006).   
Both cCF10 (pheromone) and iCF10 (inhibitor) are taken into donor Enterococcus cells 
where they bind to PrgX.  PrgX represses initiation of transcription of the plasmid-
encoded conjugation operon under normal conditions when iCF10 concentrations are far 
greater than cCF10 pheromone concentrations.   However, when recipient cells are 
nearby, the concentration of cCF10 increases and overwhelmingly binds PrgX within the 
donor cells.  cCF10 prevents the repression activity of PrgX and leads to expression of 
the conjugation operon, followed by conjugative transfer of the pCF10 plasmid 
(Kozlowicz, 2006). 
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Although conjugation has been well-studied in gram negative bacteria, especially in E. 
coli conjugation between gram positive bacteria is rare and not well understood.  The 
thick cell wall of gram positive bacteria is one of the major hurdles limiting their 
conjugative capabilities.  The cell wall of acid fast mycobacteria is even more complex 
and extremely thick.  Mycobacteria possess an inner cell membrane, which is then 
covered by a thin layer of peptidoglycan. Next, there is a complex matrix of galactan, 
arabinan, mycolic acid, and other hydrophobic molecules (Brennan, 2007). Despite this 
formidable barrier to conjugation, relaxases have been described in some gram positive 
bacteria, such as the mobilization (Mob) protein family.  This type of relaxase has been 
described in Streptococcus, Bacillus, Clostridium, Staphylococcus, and proteobacteria 
(Grohmann, 2003).  Additionally, a putative conjugative relaxase has been discovered on 
the M. avium plasmid, pVT2 (Grohmann, 2003).  The presence of relaxase genes on 
plasmids harbored by these gram positive bacteria suggests that conjugative plasmid 
transfer may proceed in a manner similar to the IncP system (Grohmann, 2003). 
Conjugative transfer of plasmids is known to occur between bacteria of the Streptomyces 
genra and the Tra protein is essential to this process.  Streptomyces Tra proteins are 
similar to known septal DNA translocator proteins.  Plasmids harbored by Streptomyces 
do not typically encode any resistance traits or virulence determinants, but simply confer 
the ability to replicate and transfer the plasmid (Grohmann, 2003), although there are 
examples of large linear plasmids which encode antibiotic biosynthetic pathways.  
Movable plasmids are often small and exist in multiple copies within a cell.  
Interestingly, one large, low-copy number plasmid has been isolated from Streptomyces 
coelicolor.  SCP2 is 31,317 bp and is able to accept large fragments of DNA, such as 
entire antibiotic biosynthetic gene clusters (Grohmann, 2003).   
1.4.1   Mycobacterial Conjugation 
The evolutionary history of M. ulcerans, namely the origin and acquisition of the 
mycolactone plasmid, continues to be investigated.  Current research postulates that M. 
ulcerans evolved from a M. marinum progenitor through acquisition of the mycolactone 
plasmid, although the original source of this plasmid remains a mystery.  However, it has 
  
29
been shown that the repA gene of pMUM001 shares 68.3% amino acid identity with the 
repA of pJAZ38, a plasmid harbored by M. fortuitum (Stinear, 2004).  The polyketide 
synthase system possessed by M. ulcerans has strong homology to two different PKS 
systems within the genome of M. marinum, but seems to be more closely related to PKS 
systems harbored by Streptomycetes (Stinear, 2008).  It is possible that M. ulcerans 
acquired a core set of PKS genes from a bacterium in the Streptomycetes genra (Stinear, 
2005) and that the mycolactone PKS system, as it exists today, has evolved as a result of 
multiple recombination and duplication events (Stinear, 2004).   
Conjugative systems in gram negative bacteria have been extensively studied and most 
often involve plasmid transfer from donor to recipient through a conjugative sex pilus.  
Double stranded plasmid DNA is nicked at a specific nic site within the oriT.  A relaxase 
binds to one strand of the nicked DNA and facilitates transfer of the single stranded DNA 
into the recipient cell.  Once in the recipient, re-circularization of the DNA is mediated 
by the same donor relaxase and does not require recipient cell recombination functions 
(Wang, 2003).    
An exception to this plasmid only rule has been discovered in Hfr (high frequency of 
recombination) strains of E. coli.  In Hfr E. coli strains, oriT (origin of transfer) sites have 
been introduced into the chromosome via integration of conjugative elements, and the 
oriT, in turn, allows E. coli to mobilize their chromosomes at a high frequency (Parsons, 
1998).  A similar phenomenon has been discovered in the fast-growing mycobacterium, 
M. smegmatis.  A DNA transfer system has been described in which multiple cis-acting 
sequences on the chromosome, designated bom (basis of mobility), mobilize sections of 
donor chromosomal DNA to recipients (Wang, 2003).   
Studies on the plasmid biology of mycobacteria and conjugation are in their infancy 
(Derbyshire).  However it is clear that the mechanism of DNA transfer in M. smegmatis 
is quite different from the classical plasmid conjugative transfer systems described in 
gram negative bacteria for two main reasons.  First of all, DNA transfer in M. smegmatis 
only occurs between distinct donor and recipient strains, as transfer of bom sequences 
from donor to recipient does not confer ability to become a donor.  This is different from 
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conjugative transfer in E. coli, where F+ donor strains transfer plasmid DNA to F- 
recipient strains.  When the F plasmid re-circularizes in the recipient strain, the oriT is 
restored, thus converting the F- recipient to an F+ donor.   
The second major difference in M. smegmatis DNA transfer is the requirement for 
recombination events in the recipient cells.  DNA transfer between M. smegmatis donor 
and recipient strains occurs as follows (1) multiple bom sequences in the donor 
chromosome mobilize segments of DNA in preparation for transfer to the recipient; (2) 
once donor chromosomal DNA is in the recipient, the recA protein facilitates a gap-repair 
like process of recombination with homologous regions of the recipient chromosome 
(Wang, 2003), (Bhatt, 2003).  This mechanism has been supported by experiments in 
which M. smegmatis bom sequences have been cloned into non-mobilizable plasmids and 
consequently these plasmids were mobilized to recipient strains (Bhatt, 2003).  Following 
the conjugal transfer of the bom-containing test plasmids into the recipient M. smegmatis 
strains, the plasmid is re-circularized not by relaxase-mediated ligation (as seen in gram 
negative conjugation systems), but rather by a mechanism similar to gap repair (Bhatt, 
2003).  The donor test plasmid is rescued by homologous recombination using the 
recipient’s chromosome as a template for gap repair of the double stranded DNA break 
(Bhatt, 2003), (Wang, 2004).  Chromosome mobilizing systems similar to the M. 
smegmatis bom system have also been observed in Streptomyces species (Parsons, 1998).  
This realization is extremely intriguing considering the fact that the M. ulcerans 
mycolactone polyketide synthase genes have homology to polyketide synthases located 
within the genome of Streptomyces.   
A recent publication reported the existence of a M. tuberculosis-specific insertion 
sequence, IS6110, in a recipient strain of M. smegmatis (Coros, 2008).  The IS6110-like 
insertion sequence has 67% amino acid identity to the native element found in M. 
tuberculosis (Coros, 2008).  The authors stipulate that the presence of this M. 
tuberculosis-specific IS element within the genome of a recipient strain of M. smegmatis 
suggests a horizontal DNA transfer event.  This is supported by the fact that many of the 
genes required for DNA transfer in M. smegmatis have been identified in M. tuberculosis 
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(Coros, 2008).  This discovery has exciting implications toward elucidating the existence 
of horizontal DNA transfer between mycobacterial species and the phenomenon will 
certainly be investigated further.  
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CHAPTER 2 : MATERIALS AND METHODS 
 
2.1   Bacterial strains and culture conditions 
The strains used in this study are listed in Table 1. Escherichia coli EC100 (Epicentre, 
Madison, Wisconsin) was cultured on Luria-Bertani (LB) with 1.5% agar (wt/vol). LB 
media was made using reagents obtained from Fisher Scientific (Fairlawn, New Jersey). 
Escherichia coli strains carrying pMYCO7017 were grown overnight at 37°C on LB agar 
or in broth containing 12.5 μg per ml Chloramphenicol (Sigma Chemical Company, St. 
Louis, Missouri). E. coli pMYCO7017::TnKm was cultured overnight at 37°C on LB 
agar or in broth containing 50 μg per ml Kanamycin (Sigma Chemical Company). 
Mycobacterial strains were cultured at 32°C in Middlebrook 7H9 broth medium (Difco 
Labs, Sparks, Maryland) or on solid media containing 1.5% wt/vol agar (Fisher 
Scientific). Middlebrook 7H9 media was always supplemented with 10% (vol/vol) oleic 
acid, albumin, dextrose supplement (OADC). Mycobacterial transformants carrying 
pMYCO7017::TnKm were grown in Middlebrook 7H9 broth medium or on agar (Difco) 
supplemented with OADC (10% vol/vol) and Kanamycin at a concentration of 50 μg per 
ml and were incubated at 32°C. 
2.2  BAC library construction and isolation of pMYCO7017 DNA 
A whole-genome M. ulcerans bacterial artificial chromosome (BAC) library was 
constructed at the Clemson University Genomics Institute as previously described 
(Tomkins, 2001). Briefly, DNA from M. ulcerans 1615 was prepared in agarose plugs, 
then partially digested with HindIII. DNA fragments were separated by PFGE, cloned 
into pBeloBAC11, and then transformed into E. coli DH10B by electroporation. The 
BAC used for this study, pMYCO7017, contains a 152 kb fragment of M. ulcerans 
plasmid DNA and includes the majority of the M. ulcerans virulence plasmid, 
pMUM001. 
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Table 1. Bacterial strain information. 
Species Strain Source a Reference 
E. coli  DH10B (pMYCO7017) CUGI This work 
 EC100 Epicentre Epicentre 
 EC100 (pMYCO7017::TnKm) UTK This work 
M. fortuitum 10394 UAM (Bachrach, 2000)  
 10394.1 (pMYCO7017::TnKm) UTK This work 
 10394.4 (pMYCO7017::TnKm) UTK This work 
 10394.6 (pMYCO7017::TnKm) UTK This work 
 10394.10 (pMYCO7017::TnKm) UTK This work 
M. marinum 1218 c ATCC 927 b (Collins, 1975) 
  1218 white mutant d UTK This work 
 DL240490 NCM (Ucko, 2005) 
 1218Y(pMYCO7017::TnKm) e UTK This work 
M. smegmatis mc2 155 AECM (Lee, 1991) 
M. ulcerans 1615 ATCC 35840 b (Pettit, 1966) 
 1615::Tn118 UTK (Stinear, 2004) 
a AECM, Howard Hughes Medical Institute, Department of Microbiology and Immunology, Albert Einstein 
College of Medicine, Bronx, NY; CUGI, Clemson University Genomics Institute, Clemson, SC, USA (Jeff 
Tomkins); NCM, Israel Oceanogrphic and Limnological Research, Ltd., National Center for Mariculture, Eilat, 
Israel; UTK, Department of Microbiology, University of Tennessee, Knoxville, TN; UAM, Universidad 
Autonoma de Madrid, Spain (M. J. Garcia); 
b ATCC, American Type Culture Collection 
c Light-inducible pigment production 
d No pigment production 
e Constitutive pigment production 
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  2.3   Pulsed field gel electrophoresis 
A freezer stock of E. coli DH10B(pMYCO7017) (Clemson University) was revived by 
thawing on ice for 10 minutes, then 100ul of cells were transferred onto LB agar 
containing Chloramphenicol at a concentration of 12.5 μg per ml.  The cultures were 
incubated overnight at 37°C. One colony was picked and inoculated into a 1 liter flask 
containing 500 ml LB broth and 12.5 μg per ml Chloramphenicol. Cultures were 
incubated at 37°C with shaking at 250 rpm for 10 hours. The QIAGEN Large Construct 
Kit was used to extract BAC DNA according to the manufacturer protocol in the 2002 
handbook (QIAGEN, Valencia, California) (Figure 7).  
The integrity and size of the DNA was verified by pulsed field gel electrophoresis 
(PFGE) using a CHEF-DR III system with a cooling module (BioRad, Hercules, 
California). An agarose gel was prepared using 1 gram of Sea Prep GTG Agarose (FMC 
BioProducts, Rockland, Maine) and 100 ml 0.5X TBE buffer (for one liter: 4.5 g tris 
base, 2.75 g boric acid, 2 ml 0.5M EDTA (pH 8.0)). 2.4 liters of 0.5X TBE buffer was 
added to the electrophoresis cell (BioRad). The buffer was pre-chilled in the chamber 
before the electrophoresis with a coolant pump, which was turned on and the temperature 
was set to 14°C. A 1 microliter slice (25 ng of DNA) of a 194 Kb low range PFG marker 
(New England BioLabs,Ipswich, Massechusetts) was loaded into the first well in the gel 
and the well was sealed with 1% agarose.  
The pMYCO7017 sample DNA was prepared as follows: 8 μl DNA, 1 μl loading dye, 1 
μl distilled, deionized water (ddH2O). Electrophoresis was run according to the following 
parameters: current 6 volts per cm, pulse angle 120°, and temperature 14°C. The ramp 
times were 3 seconds to 15.5 seconds for 12 hours followed by 15.5 seconds to 50 
seconds for 8 hours. The DNA was visualized by ethidium bromide staining and 
ultraviolet transillumination. A graph was made of the molecular weight of the band sizes 
of the 194 Kb low range PFG marker versus the distance they migrated in the gel. This 
graph was used to extrapolate the size of the pMYCO7017 DNA band, 152 Kb. 
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Figure 7. Qiagen Large Construct Protocol.  
The Large Construct Kit (QIAGEN) was used to isolate pMYCO7017 BAC DNA from 
E. coli DHB10(pMYCO7017). The protocol involves a modified alkaline lysis procedure 
followed by an ATP-dependent exonuclease digestion. DNA is bound to a resin column, 
washed, and eluted. The DNA is further concentrated by isopropanol precipitation, and 
then resuspended in an appropriate volume of TE buffer or water. (Adapted from 2002 
QIAGEN handbook.) 
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2.4   Creation of pMYCO7017::TnKm by transposon mutagenesis 
The EZ::TNTM <KAN-2> Insertion Kit (Epicentre, Madison, Wisconsin) was used to 
introduce a Kanamycin resistance transposon (Km) into pMYCO7017 by random 
mutagenesis according to the manufacturer protocol (Figure 8).  Briefly 77 ng BAC 
DNA, 1 μl 10X reaction buffer, 1 μl KAN-2 transposon, and 1 μl transposase enzyme 
were combined in a 0.2 ml tube (Eppendorf, Westbury, New York) and incubated at 37°C 
for 2 hours. The transposition reaction was stopped by adding 1 μl EZ-TN5 10X Stop 
Solution and heating at 70°C for 10 minutes. 
The new construct, pMYCO7017::TnKm, was transformed into E. coli ElectroMAX 
EC100 (Epicentre) by electroporation according to the manufacturer protocol. Briefly, 
1μl pMYCO7017::TnKm DNA and 50 μl bacterial cells were mixed and transferred to an 
electroporation cuvette. The cells were pulsed with 2.5 kV and 200 Ω resistance, then 
recovered in S.O.C. broth medium (Invitrogen) for 1 hour at 37°C with shaking at 150 
rpm. Electroporation was performed using a Gene Pulser II with pulse controller 
(BioRad) and 2mm electroporation cuvettes (Fisher Scientific, Fairlawn, New Jersey). 
The recovered bacterial cells were plated onto LB agar containing 50 μg per ml 
Kanamycin and incubated at 37°C overnight. 
 
 
 
Figure 8. Creation of pMYCO7017::TnKm. 
The EZ-Tn5 <KAN-2> transposon (Km) was randomly inserted into the DNA by 
incubating 77 ng pMYCO7017 DNA with 1 μl 10X reaction buffer, 1 μl KAN-2 
transposon, and 1 μl transposase enzyme. (Adapted from Epicentre catalogue number 
EZI982K.) 
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2.5   PCR screening of bacterial transformants 
PCR was used to select true E. coli EC100 (pMYCO7017::TnKm) transformants 
by probing for the enoyl reductase (ER) domain found within mlsA, a polyketide 
synthase gene found on pMYCO7017::TnKm. Additionally, PCR was used to find 
a clone containing a Km insertion outside the mycolactone gene cluster, 
specifically within the insertion sequence IS2606. For this particular screening, 
each clone subjected to two separate PCR reactions using primers in the following 
combinations; Kan-F with IS2606-R, and Kan-R with IS2606-F (Figure 9). Primer 
sequences are listed in Table 2.  
Reaction conditions for PCR amplification were as follows: each 50 μl reaction 
contained 1 μl each of forward and reverse primer (1.0 μM), 25 μl FailSafeTM PCR 
2X PreMix G buffer (Epicentre), 22.6 μl ddH2O, 1 unit of FailSafeTM PCR 
Enzyme Mix (Epicentre). A sterile toothpick was used to obtain bacterial cells 
which were directly added to each PCR reaction tube as a source of template 
DNA. Cycling conditions for ER were carried out as described previously 
(Williamson, 2008) in a Mastercycler (Eppendorf). Cycling conditions for both 
Kan-F/IS2606-R and Kan-R/IS2606-F reactions was as follows: initial 
denaturation at 98°C for 5 minutes, followed by 34 cycles of denaturation at 98°C 
for 1 minute, 55°C for 1 minute, 72°C for 1 minute and 30 seconds, and a final 
extension of 72°C for 10 minutes.  The 7 μl of each PCR reaction was combined 
with 1 μl 10X loading dye and samples were analyzed by electrophoresis (100 
volts for 60 minutes) using a 1% agarose (Invitrogen) and ethidium bromide. Band 
sizes were compared to a 1 kb DNA ladder (Invitrogen).  
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Figure 9. Nucleotide sequence for the <KAN-2> transposon and insertion sequence IS2606. 
The DNA sequence for the EZ-Tn5 <KAN-2> transposon was obtained from Epicentre (catalogue number EZ1982K). The boxes 
indicate the location of the Kan2-F and Kan2-R primers. The nucleotide sequence for IS2606 was obtained from the BuruList Web 
Server (http://genolist.pasteur.fr/BuruList). The highlighted areas indicate the location and sequence of the IS2606Long-F and 
IS2606Long-R primers.  
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Table 2.  Oligonucleotides used in this study. 
 
Oligonucleotide Sequence (5′Æ 3′) Description 
Kan2-F ACCTACAACAAAGCTCTCATCAACC Kanamycin transposon 
IS2606Long-R TAAGCGGCGTTTTCGGTTAG Insertion sequence 
   
IS2606Long-F CAAGACTGTCGTGGCTGTGC Insertion sequence 
Kan2-R GCAATGTAACATCAGAGATTTTGAG Kanamycin transposon 
   
parA-F CGTAGCCGTTTGGACGAC Plasmid partitioning 
parA-R GTCCTGGCGGATCTTTGAAC  
   
repA-F GCCTGGAACTCGACACCAAC Plasmid replication 
repA-R GCATCGACGCTCGCTACTTC  
   
ER-F GAGATCGGTCCCCGACGTCTAC pks enoyl reductase domain 
ER-R GGCTTGACTCATGTCACGTAAG  
   
mlsB-F CAGCCAACTGCGCTACTACA pks loading module 
mlsB-R AGGAGACACGGTTGGCTATG  
   
fabH-F GGAGATCGCCACCACCAGTGG Type III ketosynthase 
fabH-R GCACCACTTGCGCCGCATAGC  
   
mup027c-F AGCTGACCGAAGCCCTCTAC Plasmid  insertion sequence 
mup027c-R CAGTGCTCCTTGGAGGTAGG  
   
Kan118-F ACAGGATGAGGATCGTTTCG Mariner Kanamycin transposon  
Kan118-R CAATAGCAGCCAGTCCCTTC  
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2.6   Making bacterial cells electrocompetent 
Procedures were adapted from protocols described by Tanya Parish (Parish, 1998). E. 
coli EC100 (pMYCO7017::TnKm) cells were grown to mid log phase in 100 ml LB 
broth containing 50 μg per ml Kanamycin under the conditions described above. Cells 
were harvested by centrifugation in an MX-200 high speed microcentrifuge (TOMY, 
Tokyo, Japan) for 10 minutes at 3,000 x g, 4°C, washed once with a wash solution (10 
mM Tris-HCl (pH 7.5) plus 1 mM MgCl2). Washed cells were pelleted by centrifugation, 
then resuspended in 3 ml wash solution and chilled on ice for 10 minutes before use.  
Recipient mycobacteria were grown to mid log phase in 100 ml Middlebrook 7H9 broth 
under the conditions described above. Cells were harvested by centrifugation for 15 
minutes at 5,000 x g, 4°C. Cells were then made electrocompetent through a series of 
washes with ice-cold 10% sterile glycerol (ICSG) as follows; cell pellet was resuspended 
in 100 ml ICSG by vortexing, then collected by centrifugation for 15 minutes at 5,000 x 
g, 4°C. This procedure was repeated 3 times with decreasing volumes of ICSG; 50 ml, 25 
ml, and 10 ml, respectively. Mycobacterial cells were resuspended in a final volume of 3 
ml ICSG and chilled on ice for 10 minutes before use.  
2.7   Electroduction procedure 
Supplies for electroduction reactions were heat sterilized when possible and all external 
surfaces of supplies were decontaminated with 70% isopropanol. Electroduction reactions 
were performed inside a laminar flow biosafety cabinet. 350 μl of electrocompetent 
mycobacterial recipient cells (M. marinum 1218 or M. fortuitum 10394) and 50 μl 
electrocompetent E. coli EC100 (pMYCO7017::TnKm) donor cells were mixed in a 
sterile 2 ml Eppendorf tube, then transferred to an electroporation cuvette with a 0.2 mm 
gap (FisherBiotech). A Gene Pulser II (BioRad) was used to carry out the electroduction 
under the following conditions; 2.5 kV, 25 μF, and 1000 Ω pulse-controller resistance. 
For transfer of the pMYCO7017::TnKm construct from mycobacterial transformants 
back into electrocompetent E. coli, electroduction was carried out at 2.5kV, 45 μF, 
without a pulse controller. 
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 After the electric pulse, the cuvette was placed on ice for 10 minutes, then the 
electroduction suspension was transferred to a 50 ml Falcon tube (Becton Dickinson 
Labware, Franklin Lakes, New Jersey) containing 5 ml Middlebrook 7H9 broth 
supplemented with 10% OADC. Bacterial cells were allowed to recover for 2 hours at 
32°C.  Cells were then plated onto Middlebrook 7H9 agar with 10% OADC and 50 μg 
per ml Kanamycin and incubated at 32°C for 12 to 14 days. Potential transformant 
colonies were subcultured onto fresh selective media for further analysis. 
2.8   Conjugation procedure 
M. ulcerans 1615::Tn118 was used as the donor strain for the mycobacterial conjugation 
experiment.  It is a mycolactone negative mutant that was created by random mutagenesis 
using a mariner Kanamycin transposon.  M. ulcerans 1615::Tn118 and M. fortuitum 
10394 were grown to mid stationary phase in Middlebrook 7H9 broth supplemented with 
10% OADC under the appropriate conditions as described above. Filter mating between 
the donor and recipient strains was carried out as previously described (Lessard, 2004) 
with the following exceptions: media used was Middlebrook 7H9 broth or agar 
supplemented with 10% OADC; conjugation mixtures were incubated overnight at 32°C; 
following the final resuspension, 10 fold dilutions were made (10-1, 10-2, and 10-3) and 
100 μl of each dilution were plated onto selective media; plates were incubated at 37°C 
for 7-14 days or until potential transconjugant colonies appeared.  Plates were incubated 
at 37°C on selective media to kill the M. ulcerans 1615::Tn118 donor cells and encourage 
growth of and M. fortuitum 10394 transconjugants.  Each potential transconjugant colony 
was picked and vortexed in 1 ml of 0.01% SDS, then passed through a 25 gauge needle 
three times to break up large clumps of bacterial cells.  Next, ten-fold dilutions of each 
potential transconjugant suspension were made (10-1, 10-2, and 10-3) using M7H9 broth.  
Ten microliters of each 10-3 suspension was spread onto Kanamycin selective media and 
incubated at 37°C for 7 – 14 days. 
DNA was obtained from each potential transconjugant by the boil preparation method.  
One loopfull of each potential transconjugant was suspended in 400 microliters of sterile 
distilled, deionized water in a 2 ml free-standing, screw cap microtube (Denville 
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Scientfic, Inc., Metuchen, NJ).  The screw cap tubes were placed in a plastic floatation 
device and exposed to boiling water for 20 minutes.  The boil preparation tubes were 
removed from the boiling water and allowed to cool to room temperature, then 
centrifuged for 5 minutes at 4600 x g.  Three hundred microliters of supernatant was 
transferred to a new, sterile 0.2 ml Eppendorf tube and stored at 4.0°C until use.  The 
supernatant from each boil preparation contained whole cell DNA from each potential 
transconjugant. 
Whole cell DNA from each potential transconjugant colony was screen by PCR for both 
the ER domain of mycolactone gene cluster and the mariner Kanamycin transposon.  The 
oligonucleotide sequences for both ER and the mariner Kanamycin transposon can be 
found in Table 2.  Each PCR reaction was as follows: each 50 μl reaction contained 1μl 
each of forward and reverse primer (1.0 μM), 10 μl GoTaqTM 5X Green reaction buffer 
(Promega, Madison, Wisconsin), 17.6 μl ddH2O, 1 unit of GoTaqTM DNA Polymerase 
(Promega, Madison, Wisconsin), 1 μl dNTPs (Promega), and 5 μl DNA template. The 
thermocyling program used for the mariner Kanamycin transposon is as follows: initial 
denaturation at 94°C for 5 minutes, followed by 34 cycles of denaturation at 47°C for 1 
minute, 55°C for 45 seconds, 72°C for 30 seconds, and a final extension at 72°C for 10 
minutes.  The PCR amplicons were analyzed by 1% agarose gel electrophoresis with 
ethidium bromide staining and band sizes were compared to a 1 kb DNA ladder 
(Invitrogen).   
2.9   DNA extraction and PCR 
BAC DNA was extracted from mycobacterial cells by a protocol adapted from Lamour 
and Finley as described previously by Williamson et al (Williamson, 2008). Procedure 
was followed as described except that three loopfulls of each potential mycobacterial 
clone were vortexed in 400 μl lysis solution and one gram 1.0 mm glass beads (Sigma-
Aldrich).  PCR was used to probe for the following genes located on pMYCO7017; parA, 
repA, enoyl reductase domain (ER), mlsB, fabH, and mup027c. Primers used to screen 
transformants are listed in Table 2.  The thermocyling program used for mup027c is as 
follows: initial denaturation at 97°C for 3 minutes, followed by 35 cycles of denaturation 
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at 97°C for 1 minute, 59°C for 45 seconds, 72°C for 1 minute, and a final extension at 
72°C for 10 minutes. The thermocyling program used for ER was as followed described 
previously. All other thermocyling was as follows: initial denaturation at 98°C for 5 
minutes, followed by 32 cycles of denaturation at 98°C for 1 minute, 55°C for 1 minute, 
72°C for 1 minute and a final extension at 72°C for 10 minutes.  
Reaction conditions for PCR amplification were as follows: each 50 μl reaction contained 
1μl each of forward and reverse primer (1.0 μM), 25 μl FailSafeTM PCR 2X PreMix G 
buffer (Epicentre), 17.6 μl ddH2O, 1 unit of FailSafeTM PCR Enzyme Mix (Epicentre), 
and 5 μl DNA template. The PCR amplicons were analyzed by 1% agarose gel 
electrophoresis with ethidium bromide staining and band sizes were compared to a 1 kb 
DNA ladder (Invitrogen). 
2.10   Isolation and Analysis of lipids 
Lipid extraction from mycobacterial cells was performed as described previously (Mve-
Obiang, 2005). Mycobacterial cultures were grown to confluence on Middlebrook 7H9 
agar, with or without antibiotics, as described above. Lipids were extracted from 
mycobacterial pellets using chloroform : methanol (2:1) and the organic phase was dried 
down using nitrogen gas and a 50°C heat block. The lipid extract was solubilized in 
acetone (ASL) and ASLs were analyzed by thin layer chromatography as described 
previously using a solvent of chloroform : methanol : water (90:10:1) (Mve-Obiang, 
2005).   
Cell rounding and cell cycle arrest in the G0/G1 phase are typical affects observed when 
L929 murine fibroblasts are exposed to mycolactone in cell culture.  In order to ascertain 
the biological activity of the ASLs, and thus the presence or absence of mycolactone 
within the ASL extract from mycobacterial transformants, cypathicity assays were carried 
out as previously described (Snyder, 2003).  Briefly, murine L929 were grown overnight 
in Dulbecco Modified Eagle Medium (DMEM) supplemented with 5% heat-inactivated 
calf serum (Gibco BRL, Grand Island, New York) at 37°C with 5% carbon dioxide. 
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Serial 1:5 dilutions of ASLs, resuspended in ethanol, were added to L929 cultures, which 
were then observed by microscope for any cytopathic changes. 
2.11   Mass spectrometry of lipid extracts 
ASLs extracted from the different bacteria strains listed in Table 1 were analyzed using 
Shimadzu LC-20AD analytical HPLC system.  An autosampler was used to inject 50 μl 
into a reverse phase Phenomenex –luna 250X4.6 mm C18 column. Separation was 
obtained using acetonitrile /water mobile phase in a linear gradient of 55% -100% 
acetonitrile over 45 minutes at a flow rate of 2 ml per minutes.  Column elution was 
monitored using UV detection at both 254 and 360 nm. Data acquisition was controlled 
and analyzed using EZ-start 7.3 software.  
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CHAPTER 3 : RESULTS 
3.1   Analysis of pMYCO7017 
The M. ulcerans mycolactone plasmid has been difficult to study due to its low copy number and 
large size, which ranges from 155 Kb to 200 Kb across different mycolactone producing 
mycobacteria. To circumvent this difficulty, we constructed  a bacterial artificial chromosome 
(BAC) library using M. ulcerans whole-genome DNA in collaboration with the Jeff Tompkins and 
the genome center at Clemson University. During this process we were fortunate to clone nearly the 
entire mycolactone plasmid into the BAC vector as a single fragment. The resulting BAC, 
pMYCO7017, included the entire 110 kb mycolactone gene cluster.  
pMYCO7017 DNA was isolated from the E. coli transformant harboring it through the use of the 
Qiagen Large Construct kit.  The size and integrity of the DNA was checked by PFGE.  
pMYCO7017 was determined to be 152 Kb in size when compared to the 194 Kb low range PFG 
marker (Figure 10).  Additionally, the fragility of this large BAC construct is illustrated in Figure 
10 by the presence of the upper DNA band, which represents nicked and non-supercoiled DNA.   
3.2   Transposon mutagenesis of pMYCO7017 
The goal of this work was to introduce the M. ulcerans mycolactone gene cluster into a faster 
growing mycobacterial species as a first step towards achieving heterologous expression of the 
mycolactone gene cluster.  Construction of a strain with a mycolactone plasmid containing a 
selectable marker for use in mycobacteria was an essential first step for both studies on heterologous 
expression, and conjugation.  In addition, it was important that introduction of a selectable marker 
did not interrupt the genes for mycolactone biosynthesis.  The first problem encountered was that 
the BAC pMYCO7017 did not contain a good selectable marker for use in mycobacterial species.  
The BAC, pMYCO7017, contained a selectable marker chloramphenicol, but this is only useful in 
enteric bacteria and can not be used as a selectable marker in Mycobacteria species.  However,  
kanamycin provides strong selection in most species of mycobacteria.  In order to provide selection 
for pMYCO7017 in mycobacterial species, the EZ::TNTM <KAN-2> insertion kit from Epicentre 
was used to introduce a Kanamycin transposon into pMYCO7017 by random mutagenesis as 
described in the materials and  
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Figure 10. The size and integrity of pMYCO7017 was verified by pulsed field gel 
electrophoresis.  
Pulsed field gel electrophoresis of pMYCO7017.  BAC DNA was isolated from E. coli 
using the Qiagen Large Construct Kit and analyzed by PFGE under the conditions 
described.  Lane 1: 194 Kb Low range PFG Marker.  Lane 2: pMYCO7017 DNA, upper 
band contains nicked and non-supercoiled DNA; lower band contains intact, supercoiled 
pMYCO7017 DNA. 
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methods section. Two separate mutagenesis reactions were carried out. After each 
mutagenesis reaction, the resulting pMYCO7017::TnKm constructs were transformed 
into electrocompetent E. coli EC100 by electroporation.  Each set of E. coli EC100 
(pMYCO7017::TnKm) transformants was cultured on LB agar plates containing 50 μg 
per ml of Kanamycin.   
3.3   PCR screening of  E. coli transformants carrying pMYCO7017::TnKm 
3.3.1   E. coli EC100 (pMYCO7017::TnKm) transformants from first reaction 
The first Kanamycin transposon mutagenesis reaction and electroporation into E. coli 
resulted in fourteen potential E. coli EC100 (pMYCO7017::TnKm) transformants. The 
first step in analyzing the E. coli EC100 (pMYCO7017::TnKm) transformants was to 
probe them for the presence of ER, the enoyl reductase domain of the polyketide synthase 
genes mlsA1 and mlsA2.  ER can be found on pMYCO7017::TnKm and would therefore 
only be present in E. coli after a successful transformation reaction.  Through colony 
PCR, it was determined that thirteen out of the fourteen colonies from the first 
mutagenesis and electroduction reaction were positive for ER (Figure 11).  These 
thirteen colonies were subcultured onto fresh LB + Kanamycin plates for further analysis. 
 
DNA was isolated from E. coli EC100 (pMYCO7017::TnKm) transformant number 2 
and quantified by spectrophotometry to be 85 ng/μl.  The nucleotides were sequenced 
outwards from the Kanamycin transposon located on pMYCO7017::TnKm using the 
Kan2-F primer.  NCBI BLAST was used to determine that the closest match to the 
resulting DNA sequence was module 9 within a polyketide synthase gene of 
pMYCO7017::TnKm. Transformant number 2 contained a pMYCO7017::TnKm 
construct in which the Kanamycin transposon was interrupting a gene necessary for the 
production of the mycolactone toxin, and thus was not of interest for this study. 
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Figure 11. ER PCR results for potential E. coli EC100 (pMYCO7017::TnKm) 
transformants from the first mutagenesis reaction. 
Lanes 1 – 14 represent individual E. coli EC100 colonies that grew on LB + Kanamycin 
plates after the first electroporation reaction with pMYCO7017::TnKm. 
 
 
3.3.2 E. coli EC100 (pMYCO7017::TnKm) transformants from second reaction 
A second reaction, completed exactly as described previously, was carried out 
in order to introduce a Kanamycin transposon into pMYCO7017 by random 
mutagenesis. The resulting construct, pMYCO7017::TnKm, was transformed 
into E. coli EC100 by electroporation. Thirty eight potential transformant 
colonies grew on LB + Kanamycin and were subcultured onto fresh selective 
media for analysis.  
A different strategy was used for screening the second round of E. coli EC100 
pMYCO7017::TnKm) transformants than was used previously.  Colonies were 
specifically screened for the presence of the Kanamycin transposon (TnKm) 
within the insertion sequence IS2606.  This was accomplished by carrying out 
two colony PCR reactions for each transformant.  Reaction one involved the 
use of a forward primer located within IS2606 and a reverse primer located 
near the 5’ end of TnKm.  Reaction two utilized a forward primer located near 
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the 3’ end of TnKm and a reverse primer located within IS2606.  If present, the 
molecular weight of the PCR amplicon from each reaction was calculated by 
gel electrophoresis when compared to a 1 Kb molecular weight standard.  
Additionally, if a PCR product was obtained from both reactions, this indicated 
that TnKm was located completely within the boundaries of the IS2606 
element. 
A total of 38 E. coli EC100 pMYCO7017::TnKm) transformants were screened 
in this manner.  Two transformants were PCR positive for both Kan/IS2606 
reactions (Figure 12).  By adding together the combined total size of both 
amplicons, it was determined that the entire Kanamycin transposon was 
contained within an IS2606 element in the pMYCO7017::TnKm constructs 
harbored by transformants 2 and 10 (Figure 13).   
 
PCR products from transformant number 10 for both reactions (IS2606Long-
F/Kan2-R and Kan2-F/IS2606Long-R) were purified using the QIAQuick PCR 
Purification Kit (QIAGEN) and sequenced using primers specific for the 
Kanamycin transposon.  The resulting nucleotide sequence was compared to 
sequences in the database of NCBI BLAST, resulting in a match to 
Mycobacterium ulcerans insertion sequence IS2606.  Thus, the 
pMYCO7017::TnKm construct carried by E. coli transformant number 10, 
contained a selectable Kanamycin marker in an IS2606 element and not 
interrupting the mycolactone gene cluster.  This pMYCO7017::TnKm construct 
was utilized for all subsequent electroductions, with the goal of introducing the 
mycolactone gene cluster, with a selectable marker, into faster growing 
mycobacterial species. 
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Figure 12. Results of PCR screening of E. coli EC100 (pMYCO7017::TnKm) 
transformants from the second Kanamycin transposon mutagenesis reaction. 
PCR screening of E. coli EC100 (pMYCO7017::TnKm) transformants 1 through 10.  
Each lane represents the colony PCR results of an individual colony.  (A) Results of 
reaction one, using primers IS2606Long-F and Kan2-R. Colony 2 amplicon 1 size:  1200 
bp.  Colony 10 amplicon 1 size: 350 bp.  (B) Results of reaction two, using primers 
Kan2-F and IS2606Long-R.  Colony 2 amplicon 2 size: 600 bp.  Colony 10 amplicon 2 
size: 1450 bp. 
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Figure 13. Schematic representation of the location of the Kanamycin transposon 
within IS2606. 
These pMYCO7017::TnKm constructs were harbored by two different E. coli 
transformants.  Blue bars represent IS2606 DNA, aqua bars represent the Kanamycin 
transposon. (A) Transformant 2: Schematic map of TnKm location in 
pMYCO7017::TnKm harbored by E. coli transformants 2, as determined from PCR 
amplicon sizing.  (B) Transformant 10: Schematic map of TnKm location in 
pMYCO7017::TnKm harbored by E. coli transformant 10, as determined from PCR 
amplicon sizing.   
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3.4 Transfer of pMYCO7017::TnKm into mycobacteria by electroduction 
Following construction of pMYCO7017::TnKm, which contains the M. ulcerans 
polyketide synthases and polyketide-modifiying enzymes necessary for mycolactone 
production, in addition to a Kanamycin resistance gene, the next step was to try to 
introduce pMYCO7017::TnKm  into a faster growing species of mycobacteria.  The most 
common way to introduce naked DNA into bacterial cells is transformation.  The first 
step of transformation is to make the bacterial cell competent to take up foreign DNA by 
chemically weakening the cell wall, usually with calcium chloride or rubidium chloride.  
Competent cells are then mixed with the DNA of interest and transformed, either by heat 
or electrical shock.  In this study, the DNA of interest was pMYCO7017::TnKm, an 
extremely large, low copy number plasmid harbored by E. coli.  Obtaining the microgram 
amounts of intact pMYCO7017::TnKm plasmid DNA needed to carry out a successful 
transformation reaction was exceptionally difficult.  Additionally, the thick, waxy cell 
wall of mycobacteria makes transformation difficult and consequently, mycobacterial 
transformation frequency is often very low.   
In order to circumvent these difficulties, DNA can be introduced into mycobacteria by a 
process called electroduction.  “Electroduction is the direct transfer of plasmid DNA 
from one organism to another by electroporation” (Parish, 1998).  Electroduction was 
used to introduce pMYCO7017::TnKm plasmid DNA into mycobacteria.  The cell walls 
of the donor cells, E. coli EC100 (pMYCO7017::TnKm), and the recipient cells, either 
M. marinum 1218 or M. fortuitum 10394, were weakened through a series of washings, 
then they were mixed together and exposed to an electrical shock.  Table 3 contains 
results from  the multiple electroduction attempts to introduce pMYCO7017::TnKm into 
M. marinum, M. fortuitum, M. smegmatis, and M. ulcerans.  Out of 39 separate 
electroduction reactions, a total of 114 potential electroductants  grew on selective media 
and were screened for the presence of pMYCO7017::TnKm.  Eleven out of the 114 
potential electroductants were PCR-confirmed to be true, having acquired 
pMYCO7017::TnKm by electroduction.  There was 1 M. marinum electroductant and 10 
M. fortuitum electroductants. (Table 4). A more detailed description of the analysis of 
these electroductants is detailed in the next sections. 
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Table 3. Electroduction of pMYCO7017::TnKm into Mycobacterial species. 
Recipient strain Electroduction reactions 
Genotype 
ERa 
M. marinum 1218 16 1/1 
M. marinum DL240490 8 0/0 
M. smegmatis mc2155 7 0/0 
M. fortuitum 10394 6 10/113 
M. ulcerans 1615A 2 0/0 
a ER, enoyl reductase domain of the polyketide synthase gene, mlsA 
 
 
 
3.5 Analysis of M. marinum electroductant 
After sixteen separate electroduction reactions involving billions and billions 
of M. marinum cells, there was one successful electroductant, which was named 
M. marinum 1218 (pMYCO::TnKm).  The genotype of M. marinum 1218 
(pMYCO::TnKm) was confirmed by PCR, specifically probing for 6 
pMYCO7017::TnKm genes (Figure 14).  The electroductant remained PCR 
positive for the pMYCO7017::TnKm genes after multiple subcultures, proving 
that the construct could be replicated in M. marinum 1218 and effectively 
passed to successive generations (Figure 14).  This suggests that 
pMYCO::TnKm is stably maintained in M. marinum. 
Wild type M. marinum 1218 is characterized by light-inducible carotenoid 
production whereas M. ulcerans has a mutation in a key gene required for 
carotenoid biosynthesis.   However, the successful transductant was unique due 
to its constitutive carotenoid production, even in the absence of light.  The 
severity of electrical shock used during the electroduction procedure may result 
in cellular damage or mutations of this sort (personal communication).  
Additionally, most slow-growing mycobacteria have only one copy of the 
rDNA operon (Parish, 1998).  A direct mutation to this operon can often lead to 
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spontaneous resistance to chemotherapeutic agents, such as Kanamycin (Parish, 
1998). 
The ability of M. marinum 1218 (pMYCO7017::TnKm) to heterologously 
produce the mycolactone toxin was investigated in several ways.  Lipids were 
extracted from M. marinum 1218 (pMYCO7017::TnKm) cells using 
chloroform:methanol (2:1).  The acetone soluble lipids (ASLs) were analyzed 
by thin layer chromatography, cytotoxocity assay, and mass spectrometry and 
compared with ASLs from M. ulcerans 1615 or pure mycolactone.  Figure 15 
shows that mycolactone was not detected by TLC in ASLs from M. marinum 
1218 (pMYCO7017::TnKm). 
 
 
 
 
 
 
Figure 14. Gel electrophoresis results of PCR screening of the M. marinum 
transformants. 
PCR amplicons were run on a 1.5% agarose gel at 100 volts for 45 minutes.  (1) 
Kanamycin transposon, (2) parA, (3) repA, (4) mlsB, (5) ER, (6) fabH, (7) p450. 
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Table 4. Mycobacterial transformants positive for pMYCO7017::TnKm genes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 PCR target 
 
kan parA repA ER mlsB fabH mup027c a 
M. fortuitum 10394.1 (pMYCO7017::TnKm) - + + + - + - 
M. fortuitum 10394.4 (pMYCO7017::TnKm) - + + + - + - 
M. fortuitum 10394.6 (pMYCO7017::TnKm) + + + + + + + 
M. fortuitum 10394.10 (pMYCO7017::TnKm) + + + + + + + 
M. marinum 1218 (pMYCO7017::TnKm) + + + + + + NDb 
a putative transposase with homology transposases in the IS116/IS110/IS902 family identified in other 
Actinomycetales 
b ND, not done 
  
56
 
 
Figure 15. Thin layer chromatography analysis of acetone soluble lipids from M. 
marinum 1218 (pMYCO7017::TnKm). 
Mycolactone was not present in the lipid extract from the M. marinum electroductant.     
(1) ASLs from M. marinum 1218 (pMYCO7017::TnKm), (2) ASLs from M. marinum 
1218, and (3) ASLs from M. ulcerans 1615. 
 
Next, L929 murine fibroblasts were exposed to 1:5 serial dilutions of ethanol soluble 
lipids from M. marinum 1218 (pMYCO7017::TnKm).  L929 cells were observed for any 
cytopathic phenotypes and compared to cells exposed to pure mycolactone.  Figure 16 
shows the results of the cytopathicity assay after 15 hours.  Cells exposed to pure 
mycolactone rounded up and contained intra-cellular “blebs.”  L929 cells exposed to 
ASLs from the M. marinum electroductant are obviously unhealthy or even dead, but did 
not show the distinct effects seen after mycolactone exposure.  Mycobacterial ASL 
extracts are a complex mixture of lipids, and even L929 cells exposed to ASLs from wild 
type M. marinum 1218 were adversely affected.  In summary, ASLs from M. marinum 
1218 (pMYCO7017::TnKm) are damaging to L929 cells, but the affects are different 
from those seen as a result of exposure to mycolactone. 
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Finally, lipids from M. marinum 1218 (pMYCO7017::TnKm) were sent to Richard Lee 
and Engy Mahrous at the University of Tennessee Health Science Center in Memphis, 
TN for mass spectrometry analysis.  Depending on the conditions of the mass 
spectrometrometry analysis, mycolactone may be detected as an intact molecule with a 
mass of 765 (M+ + Na), 742.5, or 725 (M+ -OH) (George, 1999) (Figure 17). MS-MS 
produces fragments characteristic of the core lactone with an m/z peak at 423.3, 424, 
429.5 or 447 (M+ + Na) and the side chain may be detected in small amounts as an m/z 
peak of 359.4.  No mycolactone derived molecules were detected when the mass 
spectrum for ASLs from M. marinum 1218 (pMYCO7017::TnKm) was compared to that 
of M. ulcerans 1615 and M. marinum 1218 (Figure 18).   
Taken together, all data collected through analysis of M. marinum 1218 
(pMYCO7017::TnKm) confirms the following: (1) the M. marinum 1218 electroductant 
possesses the mycolactone gene cluster contained on pMYCO7017::TnKm; (2) M. 
marinum 1218 (pMYCO7017::TnKm) is able to replicate M. ulcerans mycolactone genes 
and pass them on to future generations; and (3) M. marinum 1218 (pMYCO7017::TnKm) 
does not produce mycolactone. 
 
 
 
 
Figure 16. Cytotoxicity assay of lipids extracted from M. marinum 1218 
(pMYCO7017::TnKm). 
L929 murine fibroblast cells after 15 hours of exposure to pure mycolactone, ASLs from 
M. marinum 1218 (pMYCO7017::TnKm), or ASLs from M. marinum 1218.   
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Figure 17. Possible fragmentation pattern of mycolactone. 
During mass spectrometry analysis, mycolactone may be detected as an intact molecule 
or it can break up to give two fragments.  (Adapted from Engy Mahrous, University of 
Tennessee, Memphis, TN) 
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Figure 18. Mass spectra of lipids extracted from M. marinum 1218 
(pMYCO7017::TnKm) vs. wild type M. marinum 1218. 
 
(A) wild type M. marinum 1218, (B) M. marinum 1218 (pMYCO7017::TnKm), and (C) 
M. ulcerans 1615. 
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3.6 Transfer of pMYCO7017::TnKm from mycobacteria back into E. coli 
In order to test the stability of the pMYCO7017::TnKm construct and to provide 
definitive proof of successful transduction, electroduction was used to transfer this BAC 
DNA from the electroductant M. marinum 1218 (pMYCO7017::TnKm) back into 
electrocompetent E. coli. THIS IS OUT OF SEQUENCE.  IT NEEDS TO GO WITH 
THE MARINUM EXPERIMENT., Two electroduction reactions were carried out and 
100 μl aliquots of the reaction mixtures were spread onto 18 separate LB + Kanamycin 
agar plates and incubated at 37°C overnight.  After incubation, all plates had colonies that 
were too numerous to count.  Seventeen were screened by colony PCR and found to be 
positive for TnKm, parA, repA, ER, and mlsB.  This experiment exemplifies the stability 
of pMYCO7017::TnKm, in that it was successfully transferred from E. coli to 
mycobacteria and back again. 
3.7 Spontaneous Kanamycin resistance 
Ideally, the outcome of attempts to transfer pMYCO7017::TnKm into M. fortuitum should have 
been easily evaluated by the ability of the organism to grow in the presence of the selectable 
marker, Kanamycin.  However, this work elucidated the fact that 80% of M. fortuitum colonies 
growing on solid media with 50 μg/ml of Kanamycin were spontaneously resistant to Kanamycin 
and did not possess the Kanamycin resistance gene or pMYCO7017::TnKm.  This background 
level of spontaneous Kanamycin resistance was observed in M. fortuitum colonies after both the 
electroduction experiments and conjugation experiments.  Spontaneous kanamycin resistance is 
commonly found in M. tuberculosis but is rare in M. ulcerans. 
 
3.8 Analysis of M. fortuitum electroductants 
Wild type M. fortuitum is known to possess multiple plasmids (Labidi, 1984), which may 
be problematic when attempting to introduce yet another, non-native plasmid into this 
species.  To avoid any potential molecular competition, a plasmid minus strain, M. 
fortuitum 10394 (Table 1) was utilized in electroduction experiments. Six separate 
electroduction reactions were carried out between E. coli EC100 (pMYCO7017::TnKm) 
  
61
and M. fortuitum 10394, resulting in hundreds of potential electroductants that grew in 
the presence of Kanamycin, the selectable marker for pMYCO7017::TnKm.  One 
hundred and thirteen colonies were screened by PCR for the presence of ER, the enoyl 
reductase domain of the polyketide synthase genes.  Out of all colonies screened, 10 M. 
fortuitum 10394 colonies were PCR positive for ER, as illustrated in Table 4. 
Two electroductants, M. fortuitum 10394.1 (pMYCO7017::TnKm) and M. fortuitum 
10394.4 (pMYCO7017::TnKm), were PCR positive for 4 out of the 6 
pMYCO7017::TnKm-specific genes, including parA, repA, ER, and fabH (Table 4).  
Two additional electroductants, M. fortuitum 10394.6 (pMYCO7017::TnKm) and M. 
fortuitum 10394.10 (pMYCO7017::TnKm), were PCR positive for all 6 
pMYCO7017::TnKm-specific genes (Table 4).  The electroductants remained PCR 
positive for the pMYCO7017::TnKm genes after multiple subcultures, proving that the 
construct could be replicated in M. fortuitum 10394 and effectively passed to successive 
generations. 
The ability of the M. fortuitum 10394 (pMYCO7017::TnKm) electroductants to 
heterologously produce the mycolactone toxin was investigated in the same manner as 
described for the M. marinum electroductants.  Lipids were extracted from the M. 
fortuitum cells using chloroform:methanol (2:1).  The acetone soluble lipids (ASLs) were 
analyzed by thin layer chromatography, cytotoxocity assay, and mass spectrometry and 
compared with ASLs from M. ulcerans 1615 or pure mycolactone.  Figure 19 shows that 
mycolactone was not detected by TLC in ASLs from M. fortuitum 10394.1 
(pMYCO7017::TnKm) or M. fortuitum 10394.4 (pMYCO7017::TnKm).  A faint band of 
significance may be visible in ASLs from M. fortuitum 10394.6 (pMYCO7017::TnKm), 
but this is speculative.  Figure 20 shows the TLC results of ASLs obtained from M. 
fortuitum 10394.10 (pMYCO7017::TnKm) compared to ASLs from M. ulcerans 1615.  
Again, there is not a distinct mycolactone band for the electroductant, however, there is 
the shadow of a band present in area of interest. 
Acetone soluble lipids from all four M. fortuitum 10394 electroductants were 
resuspended in ethanol in preparation for cytotoxicity assays (Figure 21).  L929 murine 
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fibroblasts were grown overnight at 37°C with 5%, in 96 wells plates containing DMEM.  
L929 cells were exposed to serial 1:5 dilutions of ASLs from each electroductant and 
observed for cytopathic changes.  L929 cells exposed to ASLs from M. fortuitum 10394.4 
(pMYCO::TnKm) showed different affects than cells exposed to ASLs from wild type M. 
fortuitum 10394.  However it was unclear if these affects were the same affects seen after 
exposure to pure mycolactone.  L929 fibroblast cells did not show any cytotoxic affects 
or cell rounding after exposure to ASLs from M. fortuitum 10394.1 
(pMYCO7017::TnKm), M. fortuitum 10394.6 (pMYCO7017::TnKm), or M. fortuitum 
10394.10 (pMYCO7017::TnKm). 
 
Figure 19.  TLC analysis of acetone soluble lipids from M. fortuitum electroductants 
1, 4, and 6. 
TLC analysis of acetone soluble lipids from M. fortuitum electroductants 10394.1 (lane 
1), 10394.4 (lane 2), and 10394.6 (lane 3) compared to wild type M. fortuitum 10394 
(lane 4) and pure mycolactone (lane 5).  The arrow in lane 3 points to a faint band of 
significance indicating a molecule with a similar rf to mycolactone.   
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Figure 20.  TLC analysis of M. fortuitum electroductant 10. 
TLC analysis of acetone soluble lipids from M. fortuitum 10394.10 
(pMYCO7017::TnKm) (lane 1), compared to M. ulcerans 1615 (lane 2). 
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Figure 21. Cytotoxicity assay of lipids extracted from M. fortuitum electroductants. 
Representative pictures of cytotoxicity results after L929 murine fibroblasts were 
exposed to various compounds for 26 hours. 
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Lipid extracts from the four M. fortuitum 10394 (pMYCO7017::TnKm) 
electroductants were sent to Richard Lee and Engy Mahrous at the University of 
Tennessee Health Science Center in Memphis, TN for high performance liquid 
chromatography (HPLC),  mass spectrometry (MS) analysis, and/or tandem 
MS/MS analysis. Figure 22 shows the mass spectra from wild type M. fortuitum 
10394, M.fortuitum10394.1 (pMYCO7017::TnKm), M.fortuitum10394.4 
(pMYCO7017::TnKm), and M. fortuitum 10394.10 (pMYCO7017::TnKm).  There 
were no molecules with appropriate mass or fragmentation patterns characteristic 
of mycolactone.  
High performance liquid chromatography was performed on lipids extracted from 
the M. fortuitum 10394 electroductants and compared to the HPLC profile of lipids 
from M. ulcerans 1615.  The HPLC analysis of lipids from M. ulcerans 1615, M. 
fortuitum 10394.6 (pMYCO7017::TnKm), and wild type M. fortuitum 10394 are 
illustrated in Figure 23.  Panel A shows the typical HPLC results of lipids 
extracted from M. ulcerans 1615, where the asterix indicates the mycolactone 
toxin eluting off the column at 21.6 minutes.   
There was a unique molecule contained within the lipids from M. fortuitum 
10394.6 (pMYCO7017::TnKm) that also eluted off the column at 21.6 minutes 
that was not found in wild type M. fortuitum 10394.  The lipid species eluted at 
21.6 minutes was isolated for further analysis by ESI-mass spectrometry. 
ESI-mass spectrometry analysis of the lipid species eluted off the HPLC column at 
21.6 minutes detected a molecule with a m/z of 423.3, signifying the core of the 
mycolactone toxin (Figure 24).  M. fortuitum 10394.6 (pMYCO7017::TnKm) 
possesses the mycolactone gene cluster and is able to successfully utilize the M. 
ulcerans-derived genes to heterologously produce the mycolactone core. 
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Figure 22. Mass spectra of lipids extracted from M. fortuitum electroductants 1, 4, 
and 10 compared to wild type M. fortuitum 10394. 
Mass spectra of lipid extracts from (A) wild type M. fortuitum 10394, (B) M. 
fortuitum10394.1(pMYCO7017::TnKm), (C) M.fortuitum10394.4 
(pMYCO7017::TnKm), (D) M. fortuitum 10394.10 (pMYCO7017::TnKm, and (E) and 
M. ulcerans 1615. The starred peak in panel E represents the mycolactone core. 
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Figure 23. High performance liquid chromatography of lipids extracted from M. 
fortuitum 10394.6 (pMYCO7017::TnKm) compared to controls. 
High performance liquid chromatography of lipids extracted from (A)M. ulcerans 1615, 
(B) M. fortuitum 10394.6 (pMYCO7017::TnKm), and (C) wild type M. fortuitum 10394. 
The asterisk in panel A points out the time, 21.6 minutes, when mycolactone elutes from 
the column.  The asterisk in panel B indicates a unique molecule, not found in wild type 
M. fortuitum 103941034, which also eluted at 21.6 minutes. This molecule was isolated 
for further analysis by ESI-mass spectrometry. 
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Figure 24. ESI-MS analysis of the lipid species eluted at 21.6 minutes during HPLC 
of M. fortuitum 10394.6 (pMYCO7017::TnKm). 
ESI-MS analysis of the lipid species eluted at 21.6 minutes during HPLC for (A) M. 
ulcerans 1615, (B) M. fortuitum 10394.6 (pMYCO7017::TnKm), and (C) wild type M. 
fortuitum 10394.  The asterisk in each panel indicates the core of the mycolactone toxin. 
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3.9 Conjugation using M. ulcerans 1615::Tn118 as a donor 
Electroduction reactions attempting to introduce pMYCO7017::TnKm into the mycolactone 
negative mutant, M. ulcerans 1615A, were unsuccessful.  A M. ulcerans 1615A 
(pMYCO7017::TnKm) electroductant would have been the ideal donor for conjugation 
experiments since pMYCO7017::TnKm contains the mycolactone gene cluster and it harbors a 
Kanamycin selectable marker in a non-coding region of the DNA.  Instead, M. ulcerans 
1615::Tn118 was used as the donor for the conjugation experiments.  This strain was created 
previously by Armand Mve-Obiang in Dr. Pamela Small’s lab at the University of Tennessee in 
Knoxville.  M. ulcerans 1615::Tn118 is the result of random mutagenesis using a mariner 
transposon which interrupted the FabH gene of the mycolactone gene cluster.  Thus transfer of 
this plasmid could be evaluated on the basis of growth temperature and kanamycin resistance 
although expression of mycolactone could not be evaluated.  
After filter mating between M. ulcerans 1615::Tn118 and M. fortuitum 10394, reaction mixture 
dilutions were plated on selective media and incubated at 37°C.  M. fortuitum 10394 can grow at 
this temperature, while M. ulcerans species cannot grow at 37°C.  Four hundred and eighteen 
colonies grew on the Kanamycin selective media and 100 of those colonies were subcultured for 
further study.  DNA was extracted by boil preparation as described and PCR was performed to 
probe for ER and the mariner Kanamycin transposon.  None of the 100 colonies screened were 
PCR positive for ER or the mariner Kanamycin transposon. 
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CHAPTER 4 : DISCUSSION 
 
Buruli ulcer is a devastating disease that affects thousands of people every year and yet 
the mode of transmission remains elusive.  Endemic foci are consistently found 
associated with slow moving or stagnant waters in both tropical and subtropical regions 
of the world.  Buruli ulcer disease is caused by a cutaneous infection with 
Mycobacterium ulcerans, a slow-growing, acid fast positive bacterium.  Attempts to 
culture the bacterium directly from the environment have been largely unsuccessful 
despite PCR detection of M. ulcerans DNA in various environmental samples.  
Consequently, most laboratory research has centered on M. ulcerans isolates obtained 
directly from Buruli ulcer patient lesions.   
The polyketide toxin, mycolactone, is responsible for the extensive necrosis, 
immunosuppression, and painlessness that are characteristic of Buruli ulcers.  M. 
ulcerans harbors a large, low copy number plasmid that contains the genes necessary for 
the production of mycolactone.  Plasmids are common in mycobacteria, but this is the 
first example of a mycobacterial plasmid that is directly associated with virulence.  The 
mycolactone plasmid was thought to be restricted to M. ulcerans until the recent 
discovery of several non-ulcerans mycolactone producing mycobacteria (MPM), which 
also possess versions of the mycolactone plasmid.  These MPMs have been isolated from 
frogs and fish, both in the U.S. and abroad, illustrating that mycobacteria harboring the 
mycolactone plasmid are more widely distributed in the environment than previously 
thought.   
The repertoire of tools available for the genetic manipulation of mycobacteria has been 
limited by the thick, waxy cell wall, slow growth rate, and the genome’s high G + C 
content.  Very little is known about the host range or biology of the M. ulcerans 
mycolactone plasmid for the reasons stated above, as well as its large size and low copy 
number.  Previously, experiments were carried out by Stinear and colleagues to test the 
stability of M. ulcerans’ plasmid-derived genes in the heterologous hosts M. marinum (M 
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strain), M. smegmatis (mc2155), and M. fortuitum 10394.  M. marinum was an appealing 
candidate for this experiment because of its extremely high level of genetic sequence 
similarity with M. ulcerans, including only one nucleotide difference within the 16S 
gene.  Additionally, M. ulcerans is thought to have evolved from a M. marinum 
progenitor through acquisition of the mycolactone plasmid.  M. smegmatis mc2155 is a 
highly transformable, fast-growing mycobacterial strain and considered to be the “E. 
coli” of mycobacteria.  Finally, M. fortuitum was a desirable candidate recipient for these 
studies because the rep region of the M. ulcerans plasmid has 68.3% amino acid identity 
to the rep of M. fortuitum’s plasmid, pJAZ38.  The M. fortuitum strain 10394 was chosen 
specifically because it has been cured of its own native plasmids which would 
presumably limit molecular competition within this host. 
Stinear et al cloned a 6 Kb fragment of the mycolactone plasmid into a vector, marked it 
with an apramycin resistance gene, and were able to successfully transform the construct 
into M. marinum.  The goal was to test the heterologous stability of pMUM001-derived 
genes, specifically those genes predicted to be involved with replication and partitioning 
of the mycolactone plasmid.  The ori site on the plasmid is where replication is initiated, 
specifically at the repA gene.  RepA encodes a plasmid-specific, cis-acting initiation 
protein essential to plasmid replication (Masai, 1983).  Partitioning loci, on the other 
hand, act independently of the plasmid replication machinery and are usually arranged as 
an operon that includes parA, parB, and parS (Stinear, 2005).  parB encodes a DNA 
binding protein which specifically binds to parS, a cis-acting centromere-like sequence 
(Stinear, 2005), (Masai, 1983).  The parA gene encodes a membrane associated ATPase 
that is crucial to the movement of the parB foci on the plasmid DNA (Masai, 1983).   
Stinear et al tested the stability of the M. ulcerans genes in M. marinum by allowing late 
log phase cultures of the transformant to incubate for several days without antibiotic 
induced selective pressure.  In the absence of antibiotic selection, M. marinum 
transformants subsequently lost the vector construct harboring the M. ulcerans plasmid 
genes ori, parA, and repA.  In contrast, the current work did not test the stability of the 
152 Kb mycolactone gene cluster in M. marinum transformant in the absence of antibiotic 
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selection.  Instead, M. marinum 1218 (pMYCO7017::TnKm) was passaged in the 
presence of antibiotic selection and remained PCR positive for pMYCO7017::TnKm 
specific genes for several months.  Both studies included back-transformation from M. 
marinum to E. coli as proof that the pMUM001-derived constructs were maintained as 
autonomous DNA elements in this heterologous host. 
Stinear and colleagues offer two possible explanations as to why the M. ulcerans 
mycolactone plasmid-derived construct was not maintained in M. marinum.  The first 
explanation was simply that M. marinum cannot stably maintain M. ulcerans pMUM001-
derived genes and that the putative par locus from pMUM001 is not functional in this 
species (Stinear, 2005).  A second possibility is that additional pMUM001 sequences may 
be required for plasmid maintenance that were not included in the 6 Kb pMUM001-
derived DNA fragment used for their study.  One pMUM001 sequence that was missing 
from their pMUM001-derived DNA fragment is a candidate parS site located 1.4 Kb 
upstream of parA.  The lack of the parS site within the 6 Kb pMUM001 DNA fragment 
used for their experiment may have affected plasmid partitioning to daughter cells 
(Stinear, 2005).  
The work described here had a similar goal, to investigate the stability of M. ulcerans 
mycolactone genes in a heterologous host.  To compare and contrast the work described 
here with the previous work of Stinear et al, one major difference was the vectors used 
and the size of the pMUM001-derived DNA fragment cloned into each respective vector.  
To circumvent the difficulties of working with the mycolactone plasmid in its native 
form, we utilized a 152 Kb fragment of the 155 Kb mycolactone plasmid and cloned it 
into the pBeloBAC11 vector.  The resulting bacterial artificial chromosome (BAC) could 
be carried and amplified by E. coli before transfer into other non-ulcerans mycobacteria.  
In Stinear’s work, the small size of the pMUM001-derived construct enabled the 
researchers to isolate microgram amounts of the DNA and to utilize electroporation in 
order to transform mycobacterial recipients.  In contrast, the large size of 
pMYCO7017::TnKm hindered the isolation of enough intact plasmid DNA to carryout 
electroporation experiments.  Instead, electroduction was used to transfer the 
  
73
mycolactone gene cluster, in the form of pMYCO7017::TnKm, directly from E. coli to 
M. marinum.   In both Stinear’s work and in the experiments reported here, attempts were 
made to introduce pMUM001-derived DNA into M. marinum, M. smegmatis, and M. 
fortuitum.  In both cases, no M. smegmatis mc2155 transformants were obtained.  Stinear 
and colleagues were only successful in transforming the M. marinum M strain and 
achieved 1.3 x 105 ± 0.2 transformants per microgram of plasmid DNA (Stinear, 2005).  
We were also able to successfully transfer pMUM001-derived DNA into M. marinum 
1218, however, multiple attempts to introduce pMYCO7017::TnKm into M. marinum 
strain 1218 resulted in the creation of only one successful electroductant. 
Stinear and colleagues were unable to introduce their construct into M. fortuitum 10394 
and concluded that the pMUM001-derived ori did not support replication in this species 
(Stinear, 2005).  In contrast, the present work describes the first examples of the 
successful manipulation of the entire mycolactone gene cluster, in the form of a BAC 
designated pMYCO7017::TnKm, and its introduction into faster growing mycobacterial 
species, M. fortuitum 10394.  We have shown that the pMUM001-derived construct, 
pMYCO7017::TnKm, was stably maintained in M. fortuitum 10394 under the influence 
of antibiotic selection.  Furthermore, the M. ulcerans mycolactone genes harbored by 
pMYCO7017::TnKm were at least partially expressed in M. fortuitum 10394 leading to 
the heterologous production of the mycolactone core.  It would be advantageous to 
explore why M. fortuitum 10394.6 (pMYCO7017::TnKm) was only able to produce the 
core of the mycolactone toxin.   
There may be basic difference in the biosynthetic requirements for synthesis of the 
mycolactone side chain versus the toxin core.  Alternatively, there may be unique, trans-
acting chromosomal factors present in the M. ulcerans genome required for mycolactone 
production that are absent or non-functional in M. fortuitum and M. marinum.  Once 
available, the complete genome sequence of M. fortuitum will allow further investigation 
into the intricacies of mycolactone production in this heterologous host.  However, the 
genome sequences of both M. ulcerans and M. marinum are available for comparison.   
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Dr. Armand Ove-Obiang, a post-doc in Pam Small’s lab at the University of Tennessee, 
used random transposon mutagenesis to create a library of M. ulcerans mutants.  Two of 
the M. ulcerans mutants were only able to produce the mycolactone core and had 
transposon insertions interrupting chromosomal genes; two were annotated as magnesium 
chelatase and one as a succinate dehydrogenase.  A search of the M. marinum genome 
showed that these two genes are present in this close relative of M. ulcerans.  The 
Burulist and Marinolist websites were used to obtain the protein sequence for both the 
magnesium chelatase and succinate dehydrogenase genes in M. ulcerans and M. marinum 
respectively.  MultAlin (http://bioinfo.genotoul.fr/multalin/multalin.html) was used to 
compare the protein sequences and both conserved and non-conserved amino acid 
changes were observed.  The ramifications of the amino acid changes are unclear because 
the exact role of magnesium chelatase and succinate dehydrogenase in mycolactone 
biosynthesis is not known.   It will be interesting for future research to explore the 
potential role of trans-acting genes and their involvement in the production of 
mycolactone. 
Those that continue work on this project many endeavor to more closely investigate the 
heterologous expression of M. ulcerans pMUM001-derived genes through reverse 
transcriptase – real time PCR (RT-RT PCR).  With this type of PCR, mRNA is isolated 
from bacterial cells and subjected to a reverse transcriptase reaction to create a 
complimentary DNA (cDNA) library of total cell mRNA transcripts.  Next, the cDNA is 
used a template for a real time – PCR reaction using fluorescently labeled probes specific 
for the genes of interest.  This method would enable expression-level evaluation of 
pMUM001-derived genes in heterologous host species.   
The ability to transfer the mycolactone gene cluster, in the form of pMYCO7017::TnKm,  
into various non-ulcerans mycobacterial species in the lab is certainly a noteworthy 
achievement and will prove useful in future studies.  However, electroduction as a form 
of horizontal gene transfer does not generally occur in nature and therefore, does not 
offer a realistic explanation for how M. ulcerans evolved from an M. marinum progenitor 
through acquisition of the mycolactone plasmid.  Horizontal gene transfer of plasmid 
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DNA is well documented in gram negative bacteria and gram negative mechanisms of 
conjugative transfer have been described in detail.  This is not to say that horizontal gene 
transfer as a result of conjugation does not exist in gram positive or acid fast positive 
bacteria, but merely that these systems are not well understood.   
Genetics studies of pathogenic mycobacteria, such as M. tuberculosis and M. ulcerans, 
have been specifically hindered by the genera’s slow growth, thick cell wall, and G+C 
rich genomes.  Moreover, the search for conjugative systems in mycobacteria has been 
based upon the discovery of homologous genes that have already been described in gram 
negative conjugative systems.  The inherent problem with this strategy is that 
mycobacteria may possess unique conjugative systems that have not been previously 
described.  Such is the case with the basis of mobility (bom) system described in M. 
smegmatis, the first mycobacterial conjugation system ever described (Parsons, 1998).  
M. smegmatis donor strains are able to participate in a conjugation-like event in which 
sections of the chromosome are mobilized by bom sequences and transferred to distinct 
recipient strains of M. smegmatis.  Although this newly described system is similar to the 
phenomenon observed in Hfr strains of E. coli, this conjugative system is completely 
unique and unprecedented in Mycobacteria.   
Much work remains in order to figure out the details of the exact mechanisms responsible 
for conjugative transfer of chromosomal DNA via the bom system.  However, discovery 
of this novel system does illustrate the potential for the discovery of other conjugative 
systems in mycobacteria that have not yet been discovered through genomic analysis.  
Research has suggested that M. ulcerans acquired the mycolactone plasmid through 
horizontal gene transfer and plasmid DNA transfer through the process of conjugation 
cannot be ruled out as a possibility.  Therefore, conjugation filter mating experiments 
were carried out between M. ulcerans 1615::Tn118 and M. fortuitum 10394 as a 
preliminary investigation of this possibility.  M. fortuitum 10394 is a strain that has been 
cured of its own native plasmids and should experience less molecular competition upon 
introduction of a foreign plasmid.  Additionally, the M. ulcerans mycolactone gene 
cluster (in the form of pMYCO7017::TnKm) was successfully introduced into and 
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replicated by M. fortuitum 10394.  M. fortuitum 10394 (pMYCO::TnKm) electroductants 
were able to stably replicate this plasmid.  One particular electroductant, M. fortuitum 
10394.6 (pMYCO7017::TnKm) was subsequently shown to heterologously express the 
M. ulcerans mycolactone genes leading to the production of the mycolactone core. 
The conjugation experiments between M. ulcerans 1615::Tn118 and M. fortuitum 10394 were 
carried out under the conditions described as optimal for conjugation between M. smegmatis 
donor and recipient strains (Parsons, 1998).  Filter mating is ideal because it allows close contact 
of cells at high density and allows ease of recovery of potential transconjugants (Parsons, 1998).  
Conjugation experiments performed on solid media have been shown to be drastically more 
efficient that conjugation attempts in liquid media.  Despite all attempts to maximize 
mycobacterial conjugation conditions, no transconjugants were obtained after filter mating 
experiments.  This is not discouraging, as these are only preliminary experiments.  Additionally, 
mycobacterial conjugative systems have only recently been discovered and most of the details 
remain unknown.  Certainly, future investigations into mycobacterial conjugation may shed light 
on the potential for M. ulcerans to participate in this type of horizontal gene transfer.  
This work describes the first successful transfer of the mycolactone gene cluster and subsequent 
expression of M. ulcerans mycolactone genes in a heterologous host.  The ability of M. fortuitum 
10394 to replicate pMYCO7017::TnKm and express the mycolactone polyketide synthase genes 
has important implications.  Importantly, the BAC construct pMYCO7017::TnKm may be used 
in future research to learn more about the mycolactone gene cluster and the biology of the 
mycolactone plasmid.  
 
 
 
 
 
  
77
 
 
 
 
 
 
 
 
 
REFERENCES 
 
 
 
 
 
 
 
 
 
  
78
 
REFERENCES 
 
1. Adusumilli, S., A. Mve-Obiang, T. Sparer, W. Meyers, J. Hayman, and P. L. C. 
Small. 2005. Mycobacterium ulcerans toxic macrolide, mycolactone, modulates host 
immune response and cellular location of M. ulcerans in vitro and in vivo. Cell 
Micrbiol. 7:1295-1304. 
2. Amofah, G.,  F. Bansu, C. Tetteh, J. Okrah, K. Asamoa, K. Asiedu, and J. Addy. 
2002. Buruli ulcer in Ghana: results of a national case search. Emerg. Infect. Dis. 
8:167-170. 
3. Bachrach, G., M. J. Colston, H. Bercovier, D. Bar-Nir, C. Anderson, and K. G. 
Papavinasasundaram. 2000. A new single-copy mycobacterial plasmid, pMF1, from 
Mycobacterium fortuitum which is compatible with the pAL5000 replicon. Microbiol. 
146:297-303. 
4. Bali, S. and K. J. Weissman. 2006. Ketoreduction in mycolactone biosynthesis: 
insight into substrate specificity and stereocontrol from studies of discrete 
ketoreductase domains in vitro. Chem. Biochem. 7:1935-1942. 
5. Beggs, M., J. T. Crawford, and K. D. Eisenach. 1995. Isolation and sequencing of 
the replication region of Mycobacterium avium plasmid pLR7. J. Bac. 177:4836-
4840. 
6. Beggs, M. L., H. Shiratsuchi, J. J. Ellner, and K. D. Eisenach. 1997. The 
enhancement of intracellular groth of Mycobacterium avium in human monocytes by 
plasmid pLR7. Abstr. Gen. Meet. Am. Soc. Microbiol. 97: 559. Abst. No. U89. 
7. Bhatt, A. and W. R. Jacobs, Jr. 2003. Conjugal rites of mycobacteria. Nat. Gen. 
34:3-4. 
8. Bhatt, A., H. M. Kieser, R. E. Melton, and T. Kieser. 2002. Plasmid transfer from 
Streptomyces to Mycobacterium smegmatis by spontaneous transformation. Mol. 
Microbiol. 43:135-146. 
  
79
9. Brennan, P. J. and D. C. Crick. 2007. The cell-wall core of Mycobacterium 
tuberculosis in the context of drug discovery. Curr. Top. Med. Chem. 7:475-488. 
10. Brosch, R., S. V. Gordon, A. Billault, T. Garnier, K. Eiglmeier, C. Soravito, B. G. 
Barrell, and S. T. Cole. 1998. Use of Mycobacterium tuberculosis H37Rv bacterial 
artificial chromosome library for genome mapping, sequencing, and comparative 
geonomics. Infect. Immun. 66:2221-2229. 
11. Collins, F. M., V. Montalbine, and N. E. Morrison. 1975. Growth of 
Mycobacterium marinum in thee footpads of T-cell depleted mice. Infect. Immun. 
11:1088-1093. 
12. Connor, D. H. and H. F. Lunn. 1965. Mycobacterium ulcerans infection (with 
comments on pathogenesis. Int. J. Leprosy. 33:698-709. 
13. Coros, A., E. DeConno, and K. M. Derbyshire. 2008. IS6110, a Mycobacterium 
tuberculosis complex-specific insertion sequence, is also present in the genome of 
Mycobacterium smegmatis, suggestive of lateral gene transfer among mycobacterial 
species. J. Bacteriol. 190:3408-3410. 
14. Coutanceau, E., J. Decalf, A. Martino, A. Babon, N. Winter, S. Cole, M. L. 
Albert, and  C. Demangel. 2007. Selective suppression of dendritic cell functions by 
Mycobacterium ulcerans toxin mycolactone. JEM. 204:1395-1403. 
15. Crawford, J. T. and J. H. Bates. 1979. Isolation of plasmids from mycobacteria. 
Infect. Immune.  24:979-981. 
16. Crawford, J. T., M. D. Cave, and J. H. Bates. 1981. Characterization of plasmids 
from strains of Mycobacterium avium-intracellulare. Rev. Infect. Dis. 3:949-952. 
17. Dam, T., M. Bose, M. Isa, and J. S. Virdi. 2000. Isolation of plasmids from 
Mycobacterium avium-intracellulare complex (MAC) strains from India. J. Med. 
Microviol. 49: 391-392. 
18. Debacker, M., F. Portaels, J. Aguiar, C. Steunou, C. Zinsou, W. Meyers, and M. 
Dramaix. 2006. Risk factors for buruli ulcer, Benin. EID. 12:1325-1331. 
19. Dobos, K. M., P. L. Small, M. Deslauriers, F. D. Quinn, and C. H. King. 2001. 
Mycobacterium ulcerans cytotoxicity in an adipose cell model. Infect. Immun. 
69:7182-7186. 
  
80
20. Dodge, O. G. 1964. Mycobacterial skin ulcers in Uganda: histopahological and 
experimental aspects. J. Pathol. Bacteriol. 88:167-174. 
21. En, J., M. Goto, K. Nakanaga, M. Higashi, N. Ishii, H. Saito, S. Yonezawa, H. 
Hamada, P. L. C. Small.  2008. Mycolactone is responsible for the painlessness of 
Mycobacterium ulcerans infection (Buruli Ulcer) in a murine study. Infect. Immun. 
76:2002-2007. 
22. Ferreira, R., L. S. Fonseca, A. M. Afonso, M. G. da Silva, M. H. Saad, and W. 
Lilenbaum. 2006. A report of mycobacteriosis caused by Mycobacterium marinum in 
bullfrogs (Rana catesbeiana). The Vet. J. 171:177-180. 
23. Fidanze, S., F. Song, M. Szlosek-Pinaud, P. L. Small, and Y. Kishi. 2001. 
Complete structure of the mycolactones. J. Am. Chem. Soc. 123:10117-10118. 
24. Fyfe, J. A. M, C. J. Lavender, P. D. R. Johnson, M. Globan, A. Sievers, J. 
Azuolas, and T. P. Stinear. 2007. Development and application of two multiples 
real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and 
environmental samples. Appl. Environ. Microbiol. 73:4733-4740. 
25. Gao, L. Y. and J. Maoranjan. 2006. Laboratory maintenance of Mycobacterium 
marinum. Curr. Protocol. Microbiol. DOI: 10.1002/9780471729259.mc10b01s00. 
26. Gavigan, J. A., J. A. Aίnsa, E. Pérez, E. Otal, and C. Martίn. 1997. Isolation by 
genetic labeling of new mycobacterial plasmid, pJAZ38, from Mycobacterium 
fortuitum. J. Bac. 179:4115-4122. 
27. George, K. M., L. P. Barker, D. M. Welty, and P. L. C. Small. 1998. Partial 
purification and characterization of biological effects of a lipid toxin produced by 
Mycobacterium ulcerans. Infect. Immun. 66:587-593. 
28. George, K. M., D. Chatterjee, G. Gunawardana, D. Welty, J. Hayman, R. Lee, 
and P. L. C. Small. 1999. Mycolactone: a polyketide toxin from Mycobacterium 
ulcerans required for virulence. Science. 283:854-857. 
29. George, K. M., L. Pascopella, D. M. Welty, and P. L. C. Small. 2000. A 
Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers 
and tissue culture cells. Infect. Immun. 68:877-883. 
  
81
30. Gooding, T. M., P. D. R. Johnson, D. E. Campbell, J. A. Hayman, E. L. Hartland, 
A. S. Kemp, and R. M. Robins-Browne. 2001. Immune response to infection with 
Mycobacterium ulcerans. Infect. Immun. 69:1704-1707. 
31. Grohmann, E., G. Muth, and M. Espinosa. 2003. Conjugative plasmid transfer in 
gram-positive bacteria. Microbiol. Mol. Biol. 67:277-301. 
32. Guarner, J., J. Bartlett, E. A. S. Whitney, P. L. Raghunathan, Y. Stienstra, K. 
Asamoa, S. Etuaful, E. Clutse, E. Quarshie, T. S. van der Werf, W. T. A. van der 
Graaf, C. H. King, and D. A. Ashford. 2003. Histopathologic features of 
Mycobacterium ulcerans infection. EID. 9:651-656. 
33. Hockmeyer, W. T., R. E. Krieg, M. Reich, and R. D. Johnson. 1978. Further 
characterization of M. ulcerans toxin. Infect. Immun. 21:124-128. 
34. Hong, H., T. Stinear, J. Porter, C. Demangel, and P. F. Leadlay. 2007. A novel 
mycolactone toxin obtained by biosynthetic engineering. Chem. Biochem. 8:2043-
2047. 
35. Kozlowicz, B. K., M. Dworkin, and G. M. Dunny. 2006. Pheromone-inducible 
conjugation in Enterococcus faecalis: A model for the evolution of biological 
complexity? Int. J. Med. Microbiol. 296:141-147. 
36. Krieg, R. E., W. T. Hockmeyer, and D. H. Connor. 1974. Toxin of Mycobacterium 
ulcerans. Arch. Dermatol. 110:783-788. 
37. Labidi, A., C. Dauguet, K. S. Goh, H. L. David. 1984. Plasmid profiles of 
Mycobacterium fortuitum complex isolates. Current Microbiol. 11:235-240. 
38. Labidi, A., E. Mardis, B. A. Roe, and R. J. Wallace, Jr. 1992. Cloning and DNA 
sequence of the Mycobacterium fortuitum var fortuitum plasmid pAL5000. Plasmid. 
27:130-140. 
39. Lee, M. H., L. Pascopella, W. R. Jacobs, Jr., and G. F. Hatfull. 1991. Site-specific 
integration of mycobacteriophage L5: Integration-proficient vectors for 
Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacilli Calmette-Guérin. 
Proc. Natl. Acad. Sci. 88:3111-3115. 
  
82
40. Lessard, P. A., X. M. O’Brien, D. H. Currie, and A. J. Sinkskey. 2004. pB264, a 
small, mobilizable, temperature sensitive plasmid from Rhodococcus. BMC 
Microbiology. 4:15. 
41. Masai, H., Y. Kaziro, and K. Arai. 1983. Definition of oriR, the minimum DNA 
segment essential for intiation of R1 plasmid replication in vitro.  Proc. Natl. Adad. 
Sci. 80:6814-6818. 
42. Marsollier, L., R. Robert, J. Aubry, JP. S. Andre, H. Kauakou, P. Legras, AL. 
Manceau, C. Mahaza, and B. Carbonnelle. 2002. Aquatic insects as a vector for 
Mycobacterium ulcerans. Appl. Environ. Microbiol. 68:4623-4628. 
43. Marsollier, L., Stinear, T., Aubry, J. et al. 2004. Aquatic plants stimulate the 
growth of and biofilms formation by Mycobacterium ulcerans in axenic culture and 
harbor these bacteria in the environment. Appl. Environ. Microbiol. 70:1097-1103. 
44. Meissner, P. S. and J. O. Falkinham III. 1984. Plasmid-encoded mercuric reductase 
in Mycobacterium scrofulaceum. J. Bac. 157:669-672. 
45. Mve-Obiang, A., R. E. Lee, E. S. Umstot, K. A. Trott, T. C. Grammer, J. M. 
Parker, B. S. Ranger, R. Grainger, E. A. Mahrous, and P. L. C. Small. 2005. A 
newly discovered mycobacterial pathogen isolated from laboratory colonies of 
Xenopus species with lethal infections produces a novel form of mycolactone, the 
Mycobacterium ulcerans macrolide toxin. Infect. Immun. 73:3307-3312.  
46. Parish, T. (ed.) and N. G. Stoker (ed.). 1998. Electroduction between Mycobacteria 
and E. coli , p. 136-137, Preparation of electrocompetent cells, p. 135, and Preparation 
of electrocompetent E. coli, p. 136-137. In Methods in molecular biologyTM, 
Mycobacteria protocols, vol 101. Humana Press Inc., Totowa, NJ.  
47. Parsons, L. M., C. S. Jankowski, and K. M. Derbyshire. 1998. Conjugal transfer of 
chromosomal DNA in Mycobacterium smegmatis. Mol. Microbiol. 28:571-582. 
48. Pettit, J. H. S., N. J. Marchette, and R. J. W. Rees. 1966. Mycobacterium ulcerans 
infection. Clinical and bacteriological study of the first cases recognized in South East 
Asia. Br. J. Drmatol. 78:187-197. 
49. Picardeau, M. and V. Vincent. 1997. Characterization of large linear plasmids in 
mycobacteria. J. Bac. 179:2753-2756. 
  
83
50. Portaels, F., Meyers W.M., Ablordey, A., et al. 2008. First cultivation and 
characterization of Mycobacterium ulcerans from the environment. PLoS Negl. Trop. 
Dis. 2(3): e178. Doi: 10.1371/journal.pntd.0000178. 
51. Pouillot, R. G., Matias, C. M. Wondje, F. Portaels, N. Valin, F. Ngos, A. Njikap, 
L. Marsollier, A. Fontanet, and S. Eyangoh. 2007. Risk factors for buruli ulcer: a 
case control study in Cameroon. PLoS Negl. Trop. Dis. 1(3):e101. 
Doi:10.1371/journal.pntd.0000101. 
52. Quek, T. Y. J, E. Athan,  M. J. Henry, J. A. Pasco, J. Redden-Hoare, A. Hughes, 
and P. D. R. Johnson. 2007. Risk factors for Mycobacterium ulcerans infection, 
southeastern Australia. EID. 13:1661-1666. 
53. Raghunathan, P. L., E. A. S. Whitney, K. Asamoa, et al. 2005. Risk factors for 
buruli ulcer disease (Mycobacterium ulcerans infection): results from a case-control 
study in Ghana. CID. 40:1445-1453. 
54. Ranger, B. S., E. A. Mahrous, L. Mosi, S. Adusumilli, R. E. Lee, A. Colorni, M. 
Rhodes, and P. L. C. Small. 2006. Globally distributed mycobacterial fish pathogens 
produce a novel plasmid-encoded toxic macrolide, mycolactone F. Infect. Immun. 
74:6037-6045. 
55. Read, J. K., C. M. Heggie, W. M. Meyers, and D. H. Connor. 1974. Cytotoxic 
activity of Mycobacterium ulcerans. Infect. Immun. 9:1114-1112. 
56. Rhodes, M. W., H. Kator, I. Kaattari, D. Gauthier, W. Vogelbein, and C. A. 
Ottinger. 2004. Isolation and characterization of mycobacteria from stiped bass 
Morone saxatilis from the Chesapeake Bay. Dis. Aquat. Organ. 61:41-51. 
57. Rhodes, M. W., H. Kator, S. Kotob, P. van Berkum, I. Kaattari, W. Vogelbein, F. 
Quinn, M. M. Floyd, W. R. Butler, and C. A. Ottinger. 2003. Mycobacterium 
shottsii sp. nov., a slowly growing species isolated from Chesapeake Bay striped bass, 
Morone saxatilis. Int. J. Syst. Evol. Microbiol. 53:421-424. 
58. Rhodes, M. W., H. Kator, A. McNabb, C. Deshayes, J. M. Reyrat, B. A. Brown-
Elliott, R. Wallace, Jr., K. A. Trott, J. M. Parker, B. Lifland, G. Osterhout, I. 
Kaattari, K. Reece, W. Vogelbein, and C. A. Ottinger. 2005. Mycobacterium 
pseudoshottsii sp. nov., a slowly growing chromagenic species isolated from 
  
84
Chesapeake Bay striped bass (Morone saxatilis). Int. J. Syst. Evol. Microbiol. 
55:1139-1147. 
59. Smith, S. and Shiou-Chuan Tsi. 2007. The type I fatty acid and polyketide 
synthases: a tale of two megasynthases. Nat. Prod. Rep. 24:1041-1072. 
60. Snyder, D. S. and P. L. C. Small. 2003. Uptake and cellular actions of mycolactone, 
a virulence determinant for Mycobacterium ulcerans. Microb. Path. 34:91-101. 
61. Song, L., F. Barona-Gomez, C. Corre, L. Xiang, D. W. Udwary, M. B. Austin, J. 
P. Noel, B. S. Moore, and G. L. Challis. 2006. Type III polyketide synthase beta-
ketoacyl-ACP starter unit and ethylmalonyl-CoA extender unit selectivity discovered 
by Streptomyces coelicolor genome mining. J. Am. Chem. Soc. 128:14754-14655. 
62. Stinear, T. P., G. A. Jenkin, P. D. R. Johnson, and J. K. Davies. 2000. 
Comparative genetic analysis of Mycobacterium ulcerans and Mycobacterium 
marinum reveals evidence of recent divergence. J. Bac. 182:6322-6330. 
63. Stinear, T. P., A. Mve-Obiang, P. L. C. Small, W. Frigui, M. J. Pryor, R. Brosch, 
G. A. Jenkin, P. D. R. Johnson, J. K. Davies, R. E. Lee, S. Adusumilli, T. 
Garnier, S. F. Haydock, P. F. Leadlay, and S. T. Cole. 2004. Giant plasmid-
encoded polyketide synthases produce the macrolide toxin of Mycobacterium 
ulcerans. PNAS. 101:1345-1349. 
64. Stinear, T. P., M. J. Pryor, J. L. Porter, and S. T. Cole. 2005. Functional analysis 
and annotation of the virulence plasmid pMUM001 from Mycobacterium ulcerans. 
Microbiol. 151:683-692. 
65. Stinear, T. P. et. al. 2008. Insights from the complete genome sequence of 
Mycobacterium marinum on the evolution of Mycobacterium tuberculosis. Genome 
Res. 18:729-741. 
66. Tomkins, J. P., T. C. Wood, M. G. Stacey, J. T. Loh, A. Judd, J. L. Goicoechea, 
G. Stacey. M. J. Sadowsky, and R. A. Wing. 2001. A marker-dense physical map of 
the Bradyrhizobium japonicum genome. Genome Res. 11:1434-1440. 
67. Torrado, E., S. Adusumilli, A. G. Fraga, P. L. C. Small, A. G. Castro, and J. 
Pedrosa. 2007. Mycolactone-mediated inhibition of tumor necrosis factor production 
  
85
by macrophages infected with Mycobacterium ulcerans has implications for the 
control of infection. Infect. Immun. 75:3979-3988. 
68. Trott, K .A ., B. A. Stacy, B. D. Lifland, H. E. Diggs, R. M. Harland, M. K. 
Khokha, T. C. Grammer, and J. M. Parker. 2004. Characterization of a 
Mycobacterium ulcerans-like infection in a colony of African tropical clawed frogs 
(Xenopus tropicalis). Comp. Med. 54:309-317. 
69. Ucko, M., and A. Colorni. 2005. Mycobacterium marinum infections in fish and 
humans in Israel. J. Clin. Microbiol. 43:892-895. 
70. Ucko, M., A. Colorni, H. Kvitt, A. Diamant, A. Zlotkin, and W. R. Knibb. 2003. 
Strain variation in Mycobacterium marinum fish isolates. Appl. Environ. Microbiol. 
69:5281-5287. 
71. van der Werf, T. S., T. Stinear, Y. Stienstra, W. T. A. van der Graaf, and P. L. 
Small. 2003. Mycolactones and Mycobacterium ulcerans infection. Lancet. 
362:1062-1064. 
72. van der Werf, T. S., W. T. A. van der Graaf, J. W. Tappero, and K. Asiedu. 
1999. Mycobacterium ulcerans infection. Lancet. 354:1013-1018. 
73. Wang, J. L. M. Parsons, and K. M. Derbyshire. 2003. Unconventional conjugal 
DNA transfer in mycobacteria. Nat. Gen. 34:80-84. 
74. Wang, J., and K. M. Derbyshire. 2004. Plasmid DNA transfer in Mycobacterium 
smegmatis involves novel DNA rearrangements in the recipient which can be 
exploited for molecular genetic studies.  Mol. Microbiol. 53:1233-1241. 
75. Waskar, M., D. Kumar, A. Kumar, and R. Srivastava. 2000. Isolation of a novel 
insertion sequence from Mycobacterium fortuitum using a trap vector based on 
inactivation of a lacZ reporter gene. Microbiol. 146:1157-1162. 
76. Williamson, H. R., M. E. Benbow, K. D. Nguyen, D. C. Beachboard, R. K. 
Kimbirauskas, M. D. McIntosh, C. Quaye, E. O. Ampadu, D. Boakye, R. W. 
Merritt, and P. L. C. Small. 2008. Distrobution of Mycobacterium ulcerans in 
Buruli Ulcer endemic and non-endemic aquatic sites in Ghana. PLoS Negl. Trop. Dis. 
2(3): e205. Doi:10.1371/jo 
  
86
77. Yip, M. J., J. L. Porter, J. A. M. Fyfe, C. J. Lavender, F. Portaels, M. Rhodes, H. 
Kator, A. Colorni, G. A. Jenkin, and T. Stinear. 2007. Evolution of 
Mycobacterium ulcerans and other mycolactone producing mycobacteria from a 
common Mycobacterium marinum progenitor. 189:2021-2029. 
 
 
 
 
 
 
 
 
 
 
  
87
VITA 
Samantha Elizabeth Wirth was born on October 25, 1980 in Marlton, NJ.  She spent 
most of her life in New Jersey and graduated with a B.S. in Animal Science from 
Rutgers University.  Life then led her to Knoxville, Tennessee where she worked for 
two years before applying to graduate school at the University of Tennessee in 2005.  
She joined the laboratory of Dr. Pamela Small where she focused her graduate 
education on the pathogenesis of Mycobacterium ulcerans.  In August of 2008, she 
was awarded an M.S. in Microbiology.  Currently, Samantha is a fellow in Emerging 
Infectious Disease Laboratory Training Program co-sponsored by the Centers for 
Disease Control and the Association of Public Health Laboratories.  After completing 
the one year fellowship, she plans to begin a career in infectious disease research. 
 
